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ABSTRACT  
The present study examined the effects of neonatal (postnatal days 3 and 5) acute 
immune system activation with lipopolysaccharide (LPS) on adolescent and adult anxiety 
behaviours. The major findings suggest that neonatal LPS does not have general long-lasting 
effects on adolescent anxiety and locomotor behaviours. Rather, early endotoxin treatment 
has highly specific effects on certain anxiety behaviours that vary depending on the 
development period. Moreover, neonatal LPS does not seem to influence adult voluntary and 
non-voluntary locomotor activity or anhedonia, independent of, or in response to, an adult 
immune challenge. Finally, sex differences were observed in various responses in adulthood, 
independent of neonatal drug treatment. The findings of this study provide a better 
understanding of adolescent and adult behavioural outcomes in response to endotoxin, and 
suggest that early exposure to pathogens may not be a significant risk factor in the general 
development of later anxiety disorders.  
 
Keywords: immune activation, endotoxin, lipopolysaccharide, neonatal, adolescence, adult, 
sex differences, anxiety, locomotor activity, acoustic startle response, anhedonia  
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CHAPTER 1 
General Introduction 
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1.1 General Introduction 
Early life environment plays a critical role in shaping an organism’s physiology and 
behaviour throughout the life span. Environmental events during the pre- or early post-natal 
developmental period may lead to physiological and biological changes, as well as alterations 
in the predisposition to pathology throughout development (McEwen, 2003). In humans, 
adverse and stressful experiences such as abuse, neglect, trauma and infection can increase 
susceptibility for psychopathology, including depression, anxiety, and drug abuse and 
addiction (Gilmer & McKinney, 2003; McEwen, 2003; Heim & Nemeroff, 2001). Rodent 
models are often used to examine the effects of early adverse life events on adult physiology 
and behaviour. Early stressful life events such as environmental temperature (Young, Weiss, 
& Boufath, 2002), maternal separation (daily, repeated removal of pups from mother for a 
length of time over the first weeks of life) (Plotsky & Meaney, 1993; Kalinichev, Easterling, 
Plotsky, & Holtzman, 2002), neonatal isolation (Knuth & Etgen, 2005; 2007) and handling 
(Durand, Sarriaeu, Aguere, Mormede, & Chaouloff, 1998) can induce long-lasing alterations 
in physiological and behavioural processes. These changes include increased stress response 
of the hypothalamic-pituitary-adrenal (HPA) axis (Kehoe, Shoemaker, Triano, Callahan, & 
Rappolt, 1998; Liu, Caldji, Sharma, Plotsky, & Meaney, 2000; Walker, Hodyl, Krivanek, & 
Hodgson, 2006), increasing levels of anxiety-like behaviour (Kalinichev et al., 2002; Daniels, 
Pieterson, Carstens, & Stein, 2004; Walker, March, & Hodgson, 2004b; Knuth & Etgen, 
2007) and enhanced sensitivity to drugs of abuse (Kosten, Sanchez, Zhang, & Kehoe, 2004; 
Kikusui, Faccidomo, & Miczek, 2005).  
The early postnatal period is a challenging developmental time period with regard to 
exposure to pathogens. The immunological system involved in the regulation of bacterial 
activity is not fully developed in early life (Walker, Hodyl, Krivanek, & Hodgson, 2006). 
Given the underdeveloped state of the neonatal immune system, a neonate has a potentially 
increased risk of developing a bacterial infection. Furthermore, there are bidirectional 
interactions between the immune and endocrine systems. Proinflammatory cytokines 
produced in response to immune system activation result in a response in the HPA axis, and 
hormones such as glucocorticoids produced in the endocrine system modulate immune 
system function (Imura & Fukata, 1994). As such, alterations in one system during 
development may have consequences for the other system and these effects may extend to 
adulthood (Tenk, 2007).  
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Accumulating evidence has emphasized the role of early bacterial and viral exposure 
on long-term physiological and behavioural processes. In humans, prenatal exposure to 
infection has been implicated in an increased risk of neurodevelopmental disorders such as 
schizophrenia (Brown, 2006; Ashdown, Dumont, Ng, Poole, Boksa, & Luheshi, 2006; 
Gilmore, Jarskog, Vadlamudi, & Lauder, 2004) and autism (Taylor & Rogers, 2005). Results 
of animal studies have also demonstrated an enhanced vulnerability to psychopathology in 
adulthood following an early life immune challenge. For example, exposure to pathogens 
prenatally results in deficits in behaviours relevant to schizophrenia (Shi, Fatemi, Sidwell, & 
Patterson, 2003; Fortier, Joober, Luheshi, & Boksa, 2004; Fortier, Luheshi, & Boksa, 2007). 
Furthermore, prenatal immune activation has been shown to result in increased susceptibility 
to drug abuse (Liu, Lee, Yee, Bresee, Poland, & Pechnick, 2004).  
More recent research has demonstrated a need to more thoroughly consider the effects 
of neonatal infections on later physiology and behaviour. For example, neonatal bacterial 
exposure has been indicated to result in adult deficits in behaviour implicated in autism and 
schizophrenia, such as reductions in social interaction (Tohmi, Tsuda, Watanabe, Kakita, & 
Nawa, 2004). This research, as well as other studies examining the risk of psychopathology 
following neonatal immune activation, is of particular interest given the vulnerability of the 
neonatal developmental period with regard to pathogen exposure. 
The endotoxin lipopolysaccharide (LPS) is the active component of the cell wall of 
Gram-negative bacteria, and stimulates the immune and endocrine systems. LPS 
administration activates the peripheral immune cells, monocytes and macrophages (Dantzer, 
2001), and results in the release of proinflammatory cytokines such as interleukin (IL)-1β, 
tumor-necrosis-factor (TNF)-α, and interleukin (IL)-6. These cytokines target sites within the 
central nervous system and elicit a response mimicking infectious illness by producing a 
variety of physiological and behavioural symptoms. This characteristic set of adaptive 
responses is known as the acute phase sickness response. Such responses include fever 
(Gaykema, et al., 1998) and reduction in food (Hart, 1988) and water intake (Cross-Mellor, 
Kent, Kavaliers, & Ossenkopp, 2000). Additionally, LPS administration leads to hypoactivity 
(Engeland, Kavaliers, & Ossenkopp, 2003a; Franklin, Engeland, Kavaliers, & Ossenkopp, 
2003) decreased sexual activity (Avitsur, Pollak, & Yirmiya, 1997) and exploratory 
behaviour (Nava, et al., 1997) and release of the stress-related hormone corticosterone as the 
end product of activation of the hypothalamic–pituitary–adrenal (HPA) axis (Nakano, 
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Suzuki, & Oh, 1987; Tenk, Kavaliers, & Ossenkopp, 2008). Sickness behaviour is considered 
to be the expression of an organized and adaptive strategy to combat invading pathogens and 
increase the likelihood of survival (Dantzer, 2001). Early exposure to LPS induces the same 
set of acute sickness responses observed in adulthood, including anorexia, hypoactivity, and 
activation of the HPA axis (Walker, Brogana, Roger, & Hodgson, 2004a; Dent, Smith, & 
Levine, 1999).  
Immune system functioning has been shown to be sexually dimorphic in both adults 
and neonates. Generally, adult females show enhanced functioning of both humoral- and cell-
mediated immunity relative to males (Gaillard & Spinedi, 1998). These effects are mediated 
by gonadal hormones, as estrogen exerts immune-enhancing effects (Friedman, Netti, & 
Schreiber, 1985; Giglio, et al., 1994), whereas testosterone has immunosuppressive effects 
(Klein, 2000; Roden, et al., 2004). Furthermore, females demonstrate greater basal levels of 
corticosterone and display greater and more rapid increases following stressors such as LPS 
administration (Critchlow, Liebelt, Bar-Sela, Mountcastle, & Lipscomb, 1963; Kant, Lenox, 
Bunnell, Mougey, Pennington, & Meyerhoff, 1983). Similar sex differences in the acute 
response to neonatal LPS exposure have also been observed. Consistent with adult findings, 
female neonates demonstrate greater HPA axis activation, as well as greater levels of 
adrenocorticotropic hormone and corticosterone in response to neonatal LPS administration 
(Shanks, McCormick, & Meaney, 1994). 
A relatively smaller number of studies have explored the effects of early immune 
system activation on adult physiological and behavioural processes. During the neonatal 
period rodents demonstrate a very weak stress response following exposure to stressful 
stimuli (Vazquez, 1998). This period is considered the “stress hyporesponsive period” and 
coincides with postnatal days 4/5 to postnatal day 12. The HPA axis response is limited, 
including a reduction in the release of corticosterone and adrenocorticotropic hormone 
(Vazquez, 1998; Tenk, 2007). With regard to neonatal LPS administration, studies often use 
one of two different treatment protocols. The first protocol involves two administrations of 
LPS on postnatal days 3 and 5 (e.g. Shanks, McCormick, & Meaney, 1994; Breivik, Stephan, 
Brabant, Straub, Pabst, & von Hörsten, 2002; Walker, March, & Hodgson, 2004a) and is 
termed the “dual-exposure-to-endotoxin” (DEE) model. The first exposure to LPS on 
postnatal day 3 is prior to the onset of the stress hyporesponsive period, and therefore pups 
exhibit an increased HPA axis response to endotoxin (Shanks & Meaney, 1994; Witek-
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Janusek, 1998). HPA activation following a single neonatal endotoxin injection persists for 
slightly less than 48 hr, and therefore, a second injection on postnatal day 5 induces an 
immune system activation that spans postnatal days 3 to 7 of life (Shanks & Meaney, 1994). 
The second neonatal endotoxin exposure regime involves a single administration of LPS on 
postnatal day 14, following the conclusion of the stress hyporesponsive period (Boisse, 
Mouihate, Ellis, & Pittman, 2004; Spencer, Heida, & Pittman, 2005; Spencer, Boisse, 
Mouihate, & Pittman, 2006a).  
Examination of the long-term effects of neonatal immune system activation reveals a 
variety of physiological changes in adulthood. For instance, the DEE model induces 
heightened responsivity to different forms of stress (Shanks et al., 1995; Shanks, et al., 2000), 
as well as increased disease severity (Breivik et al., 2002) and impaired tumor resistance in 
adulthood (Hodgson, Knott, & Walker, 2001). LPS administration in later neonatal 
development also produces changes in adulthood, although these effects are not necessarily 
the same as those observed with the DEE model. For example, exposure to LPS on postnatal 
day 14 has been shown to result in immune system tolerance in adulthood. Rodents 
demonstrate a decrease in cytokine release when administered LPS on postnatal day 14 
(Ellis, Mouihate, & Pittman, 2005), as well as an attenuation of the febrile response 
following LPS in adulthood (Boisse, Mouihate, Ellis, & Pittman, 2004; Spencer, Boisse, 
Mouihate, & Pittman, 2006a). Several studies have also examined the long-term behavioural 
consequences of neonatal LPS exposure, and have demonstrated alterations in anxiety-related 
behaviour. However, results from studies utilizing the DEE model, as well as those with later 
neonatal exposure, show that anxiety-related behaviour is test specific, with increases seen on 
some tests but decreases on others (Breivik et al., 2002; Walker, March, & Hodgson, 2004b; 
Spencer et al., 2005).  
Given the conflicting results, as well as the limited research regarding several areas of 
early immune activation, it is of interest to examine the effects of early immune system 
activation at various developmental periods. Moreover, given the sexual dimorphism in 
immune system functioning and response to endotoxin, an investigation of possible sex 
differences in these effects is warranted. Thus, the present thesis conducted a detailed 
examination of neonatal immune system activation with LPS using the DEE model on 
adolescent and adult behaviour in male and female Long-Evans rats. This thesis investigated 
behaviours that have previously been shown to be altered following other adverse neonatal 
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manipulations, such as endotoxin exposure and maternal separation, as well as possible sex 
differences in these effects.  
The first study presented in this thesis explored the effects of neonatal LPS treatment 
using the DEE model on adolescent anxiety-related behavioural responses. Previous research 
has demonstrated inconsistent results in terms of alterations in immune functioning and 
behaviour, and there is limited research examining the consequences of early immune system 
activation in adolescence. Given the purported anxiogenic effects of acute LPS 
administration (Lacosta, Merali, & Anisman, 1999; Nava & Carta, 2001), anxiety-related 
changes are of particular interest. Thus, this study used multiple measures of anxiety-related 
behaviours including the elevated plus maze (Moser, 1989; Rodgers & Dalvi, 1997; Walf & 
Frye, 2007), open-field (Ossenkopp & Kavaliers, 1996), and light dark tests (Crawley & 
Goodwin, 1980). These experiments were designed to further investigate the effects of early 
immune system activation on anxiety during a significant developmental period, as well as 
possible sex differences in these responses. 
The second study described in Chapter 3 explored the effects of neonatal LPS 
adminstration on anxiety-related behavioural responses in adulthood. Previous research has 
shown altered adult immune functioning following DEE, but findings have been inconsistent 
(Breivik et al, 2002; Walker et al., 2006). Furthermore, there is limited research investigating 
the effects of early immune system challenge on non-voluntary sensorimotor reflexes. As 
such, the second experiment examined the effects of neonatal LPS administration on adult 
anxiety-related behaviours, unaccompanied by additional manipulations, as well as following 
an additional immune system challenge with LPS. This study used multiple indices of 
anxiety, including the elevated plus maze (Moser, 1989; Rodgers & Dalvi, 1997; Walf & 
Frye, 2007), light dark tests (Crawley & Goodwin, 1980) and taste neophobia (Merali, Levac, 
& Anisman, 2003; Dulawa & Hen, 2005). Additionally, the acoustic startle response and PPI 
(Lockey, Kavaliers, & Ossenkopp, 2009) were utilized as novel behavioural measures of the 
effects of early immune manipulation on non-voluntary motor activity. Possible sex 
differences in these anxiety responses were also explored. 
The results of the current thesis provide a detailed examination of the effects of 
neonatal (DEE) LPS treatment on behaviour throughout development, including the 
behavioural consequences during adolescence and adulthood. Furthermore, possible sex 
differences in these outcomes are also investigated. The findings presented in this thesis lead 
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to a better understanding of potential risk factors involved in early endotoxin exposure, such 
as bacterial infection with Gram negative bacteria. These studies have clinical implications 
for the effects of early bacterial exposure on later infections at various developmental 
periods, as well as the development of anxiety-disorders. 
  
8 
 
1.2 References 
Ashdown, H., Dumont, Y., Ng, M., Poole, S., Boksa, P., & Luheshi, G. (2006). The role of 
cytokines in mediating effects of prenatal infection on the fetus: Implications for 
schizophrenia. Molecular Psychiatry, 11, 47–55. 
Avitsur, R., Pollak, Y., & Yirmiya, R. (1997). Different receptor mechanisms mediate the 
effects of endotoxin and interleukin-1 on female sexual behaviour. Brain Research, 
773, 149-161. 
Boisse, L., Mouihate, A., Ellis, S., & Pittman, Q. (2004). Long-term alterations in 
neuroimmune responses after neonatal exposure to lipopolysaccharide. Journal of 
Neuroscience, 23, 4928-4934. 
Breivik, T., Stephan, M., Brabant, G. E., Straub, R. H., Pabst, R., & von Hörsten, S. (2002). 
Postnatal lipopolysaccharide-induced illness predisposes to periodontal disease in 
adulthood. Brain, Behaviour, and Immunity, 16, 421–438. 
Brown, A. (2006). Prenatal infection as a risk factor for schizophrenia. Schizophrenia 
Bulletin, 32, 200-202. 
Critchlow, V., Liebelt, R., Bar-Sela, M., Mountcastle, W., & Lipscomb, H. (1963). Sex 
difference in resting pituitary-adrenal function in the rat. American Journal of 
Physiology, 205, 807-815. 
Crawley, J., & Goodwin, F. (1980). Preliminary report of a simple animal behaviour model 
for the aniolytic effects of benzodiazepines. Pharmacology Biochemistry and 
Behaviour, 13, 167–170. 
Cross-Mellor, S., Kent, W., Kavaliers, M., & Ossenkopp, K.-P. (2000). Examining the 
effects of lipopolysaccharide and cholecystokinin on water ingestion: Comparing 
intake and palatability. Brain Research, 861, 220-232. 
Daniels, W., Pieterson, C., Carstens, M., & Stein, D. (2004). Maternal separation in rats leads 
to anxiety-like behaviour and a blunted ACTH response and altered neurotransmitter 
levels in response to a subsequent stressor. Metabolic Brain Disease, 19, 3-14. 
Dantzer, R. (2001). Cytokine-induced sickness behaviour: Where do we stand? Brain 
Behaviour and Immunity, 15, 7-24. 
Dent, G., Smith, M., & Levine, S. (1999). The ontogeny of the neuroendocrineresponse to 
endotoxin. Developmental Brain Research, 117 (1), 21–29. 
9 
 
Dulawa, S., & Hen, R. (2005). Recent advances in animal models of chronic antidepressant 
effects: The novelty-induced hypophagia test. Neuroscience & Biobehavioural 
Reviews, 29, 771-783. 
Durand, M., Sarriaeu, A., Aguere, S., Mormede, P., & Chaouloff, F. (1998). Differential 
effects of neonatal handling on anxiety, corticosterone response to stress, and 
hippocampal glucocorticoid and serotonin (5-HT) receptors in lewis rats. 
Psychoneuroendocrinology, 23, 323-335. 
Ellis, S., Mouihate, A., & Pittman, Q. (2005). Early life immune challenge alters innate 
immune responses to lipopolysaccharide: Implications for host defense as adults. 
FASEB Journal, 19, 1519-1521. 
Engeland, C., Kavaliers, M., & Ossenkopp, K.-P. (2003a). Sex differences in the effects of 
muramyl dipeptide and lipopolysaccharide on locomotor activity and the 
development of behavioural tolerance in rats. Pharmacology, Biochemistry and 
Behaviour, 74, 433-447. 
Fortier, M., Joober, R., Luheshi, G., & Boksa, P. (2004). Maternal exposure to bacterial 
endotoxin during pregnancy enhances amphetamine-induced locomotion and startle 
responses in adult rat offspring. Journal of Psychiatric Research, 38, 335–345. 
Fortier, M., Luheshi, G., & Boksa, P. (2007). Effects of prenatal infection on prepulse 
inhibition in the rat depend on the nature of the infectious agent and the stage of 
pregnancy. Behavioural Brain Research, 181, 270–277. 
Franklin, A., Engeland, C., Kavaliers, M., & Ossenkopp, K.-P. (2003). Lipoplysaccharide-
induced hypoactivity and behavioural tolerance development are modulated by the 
light-dark cycle in male and female rats. Psychopharmacology (Berlin), 170, 399-408. 
Friedman, D., Netti, F., & Schreiber, A. (1985). Effect of estradiol and steroid analogues on 
the clearance of immunoglobulin G-coated erythrocytes. Journal of Clinical 
Investigation, 75, 162-167. 
Gaykema, R., Goehler, L., Tilders, F., Bol, J., McGorry, M., Fleshner, M., et al. (1998). 
Bacterial endotoxin induces fos immunoreactivity in primary afferent neurons of the 
vagus nerve. Neuroimmunomodulation, 5, 234-240. 
Giglio, T., Imro, M., Filaci, G., Scudeletti, M., Puppo, F., De Cecco, L., et al. (1994). 
Immune cell circulating subsets are affected by gonadal function. Life Sciences, 54, 
1305-1312. 
10 
 
Gilmer, W., & McKinney, W. (2003). Early experience and depressive disorders: Human and 
non-human primate studies. Journal of Affective Disorders, 75, 97-113. 
Gilmore, J. H., Jarskog, L. F., Vadlamudi, S., & Lauder, J. M. (2004). Prenatal infection and 
risk for schizophrenia: IL-Iβ, IL-6, and TNFα inhibit cortical neuron dendrite 
development. Neuropsychopharmacology, 29, 1221-1229. 
Hart, B. (1988). Biological basis of the behaviour of sick animals. Neuroscience and 
Biobehavioural Reviews, 12, 123-137. 
Heim, C., & Nemeroff, C. (2001). The role of childhood trauma in the neurobiology of mood 
and anxiety disorders: Preclinical and clinical studies. Biological Psychiatry, 49, 
1023-1039. 
Hodgson, D., Knott, B., & Walker, F. (2001). Neonatal endotoxin exposure influences HPA 
responsivity and impairs tumor immunity in Fischer 344 rats in adulthood. Pediatric 
Research, 50, 750–755. 
Imura, H., & Fukata, J.-i. (1994). Endocrine-paracine interaction in communication between 
the immune and endocrine systems. Activation of the hypothalamic-pituitary-adrenal 
axis in inflammation. European Journal of Endocrinology, 130, 32-37. 
Kalinichev, M., Easterling, K. W., Plotsky, P. M., & Holtzman, S. G. (2002). Long-lasting 
changes in stress-induced corticosterone response and anxiety-like behaviours as a 
consequence of neonatal maternal separation in Long-Evans rats. Pharmacology 
Biochemistry and Behaviour, 73, 131-140. 
Kant, G., Lenox, R., Bunnell, B., Mougey, E., Pennington, L., & Meyerhoff, J. (1983). 
Comparison of stress response in male and female rats: Pituitary cyclic AMP and 
plasma prolactin, growth hormone and corticosterone. Psychoneuroendocrinology, 8, 
421-428. 
Kehoe, P., Shoemaker, W., Triano, L., Callahan, M., & Rappolt, G. (1998). Adult rats 
stressed as neonates show exaggerated behavioural responses to both 
pharmacological and environmental challenges. Behavioural Neuroscience, 112, 116-
125. 
Kikusui, T., Faccidomo, S., & Miczek, K. (2005). Repeated maternal separation: Differences 
in cocaine-induced behavioural sensitization in adult male and female mice. 
Psychopharmacology, 178, 202-210. 
11 
 
Klein, S. (2000). Hormones and mating system affect sex and species differences in immune 
function among vertebrates. Behavioural Processes, 51, 149–166. 
Knuth, E., & Etgen, A. (2005). Corticosterone secretion induced by chronic isolation in 
neonatal rats is sexually dimorphic and accompanied by elevated ACTH. Horomones 
and Behaviour, 47, 65-75. 
Knuth, E., & Etgen, A. (2007). Long-term behavioural consequences of brief, repeated 
neonatal isolation. Brain Research, 1128, 139-147. 
Kosten, T., Sanchez, H., Zhang, X., & Kehoe, P. (2004). Neonatal isolation enhances 
acquisition of cocaine self-administration and food responding in female rats. 
Behavioural Brain Research, 151, 137-149. 
Lacosta, S., Merali, Z., & Anisman, H. (1999). Behavioural and neurochemical consequences 
of lipopolysaccharide in mice: anxiogenic-like effects. Brain Research, 818, 291-303. 
Liu, D., Caldji, C., Sharma, S., Plotsky, P., & Meaney, M. (2000). Influence of neonatal 
rearing conditions on stress-induced adrenocorticotropin responses and 
norepinepherine release in the hypothalamic paraventricular nucleus. Journal of 
Neuroendocrinology, 12, 5-12. 
Liu, X., Lee, J., Yee, S., Bresee, C., Poland, R., & Pechnick, R. (2004). Endotoxin exposure 
in utero increases ethanol consumption in adult male offspring. Neuroreport, 15, 203-
206. 
Lockey, A., Kavaliers, M., & Ossenkopp, K.-P. (2009). Lipopolysaccharide produces dose-
dependent reductions of the acoustic startle response without impairing prepulse 
inhibition in male rats. Brain, Behaviour, and Immunity, 23, 101–107. 
McEwen, B. S. (2003). Early life influences on life-long patterns of behviour and health. 
Mental Retardation and Developmental Disabilities Research Reviews, 9, 149-154. 
Merali, Z., Levac, C., & Anisman, H. (2003). Validation of a simple, ethologically relevant 
paradigm for assessing anxiety in mice. Biological Psychiatry, 54, 552-565. 
Moser, P. (1989). An evaluation of the plus-maze test using the novel anxiolytic buspirone. 
Psychopharmacology, 99, 48-53. 
Nakano, K., Suzuki, S., & Oh, C. (1987). Significance of increased secretion of 
glucocorticoids in mice and rats injected with bacterial endotoxin. Brain, Behaviour 
and Immunity, 1 (2), 159–172. 
12 
 
Nava, F., & Carta, G. (2001). Melatonin reduces anxiety induced by lipopolysaccharide in 
the rate. Neuroscience Letters, 307, 57-60. 
Nava, F., Calapai, G., Facciola, G., Cuzzocrea, S., Marciano, M., De Sarro, A., & Caputi, A. 
P. (1997). Effects of interleukin-10 on water intake, locomotor activity and rectal 
temperature in rat treated with endoxin. International Journal of 
Immunopharmacology, 19, 31-38. 
Ossenkopp, K.-P., & Kavaliers, M. (1996). Measuring spontaneous locomotor activity in 
small mammals. In K.-P. Ossenkopp, M. Kavaliers, & P. (. Samberg, Measuring 
movemetn and locomotor: From invertebrates to humans (pp. 33-59). Georegtown, 
TX: Landes Company. 
Plotsky, P., & Meaney, M. (1993). Early postnatal experience alters hypothalamic 
corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and 
stress-induced release in adult rats. Molecular Brain Research, 18, 195-200. 
Roden, A., Moser, M., Tri, S., Mercade, M., Kuntz, S., Dong, H., et al. (2004). Augmentation 
of T cell levels and responses induced by androgen deprivation. The Journal of 
Immunology, 173, 6098-6108. 
Rodgers, R., & Dalvi, A. (1997). Anxiety, defence and the elevated plus-maze. Neuroscience 
and Biobehavioural Reviews, 21, 801–810. 
Shanks, N., & Meaney, M. (1994). Hypothalamic-pituitary-adrenal activation following 
endotoxin administration in the developing rat: A CRH-mediated effect. Journal of 
Neuroendocrinology, 6, 375–383. 
Shanks, N., Larocque, S., & Meaney, M. (1995). Neonatal endotoxin exposure alters the 
development of the hypothalamic-pituitary-adrenal axis: Early illness and later 
responsivity to stress. The Journal of Neuroscience, 15 (1), 376-384. 
Shanks, N., McCormick, C., & Meaney, M. (1994). Sex differences in hypothalamic-
pituitary-adrenalresponding to endotoxinchallenge in the neonate: Reversal by 
gonadectomy. Developmental Brain Research, 79, 260–266. 
Shanks, N., Windle, R., Perks, P., Harbuz, M., Jessop, D., Ingram, C., et al. (2000). Early-life 
exposure to endotoxin alters hypothalamic-pituitary-adrenal function and 
predisposition to inflammation. Proceedings of the National Academy of Sciences of 
the United States of America, 97 (10), 5645-5650. 
13 
 
Shi, L., Fatemi, S., Sidwell, R., & Patterson, P. (2003). Maternal influenza infection causes 
marked behavioural and pharmacological changes in the offspring. Journal of 
Neuroscience, 3, 297-302. 
Spencer, S. J., Boisse, L., Mouihate, A., & Pittman, Q. J. (2006a). Long term alterations in 
neuroimmune responses of female rats after neonatal exposure to lipopolysaccharide. 
Brain Behaviour and Immunity, 20, 231-238. 
Spencer, S., Heida, J., & Pittman, Q. (2005). Early life immune challenge - effects on 
behavioural indices of adult rat fear and anxiety. Behavioural Brain Research, 164, 
231-238. 
Taylor, E., & Rogers, J. (2005). Practitioner review: Early adversity and developmental 
disorders. Journal of Child Psychology and Psychiatry, 46, 231-238. 
Tenk, C. M. (2007). Adult behavioural outcomes of neonatal immune system activation with 
lipopolysaccharide. University of Western Ontario, Psychology. London: 
Unpublished doctoral dissertation. 
Tenk, C., Kavaliers, M., & Ossenkopp, K.-P. (2008). Sexually dimorphic effects of neonatal 
immune system activation with lipopolysaccharide on the behavioural response to a 
homotypic adult immune challenge. International Journal of Developmental 
Neuroscience, 26, 331-338. 
Tohmi, M., Tsuda, N., Watanabe, Y., Kakita, A., & Nawa, H. (2004). Perinatal inflammatory 
cytokine challenge results in distinct neurobehavioural alterations in rats: Implication 
in psychiatric disorders of developmental origin. Neuroscience Research, 50, 67-75. 
Vazquez, D. (1998). Stress and the developing limbic-hypothalamic-pituitary-adrenal axis. 
Psychoneuroendocrinology, 23, 663-700. 
Walf, A., & Frye, C. (2007). The use of the elevated plus maze as an assay of anxiety-related 
behaviour in rodents. Nature Protocols, 2, 322-238. 
Walker, F. R., Brogana, A., Roger, S., & Hodgson, D. M. (2004a). A profile of the 
immediate endocrine, metabolic and behavioural responses following a dual exposure 
to endotoxin in early life. Physiology and Behaviour, 83, 495-504. 
Walker, F. R., Hodyl, N. A., Krivanek, K. M., & Hodgson, D. M. (2006). Early life host–
bacteria relations and development: Long-term individual differences in 
neuroimmune function following neonatal endotoxin challenge. Physiology & 
Behaviour, 87, 126-134. 
14 
 
Walker, F., March, J., & Hodgson, D. (2004b). Endotoxin exposure in early life alters the 
development of anxiety-like behaviour in the Fischer 344 rat. Behavioural Brain 
Research, 154, 63-69. 
Witek-Janusek. (1998). Pituitary-adrenal response to bacterial endotoxin in developing rats. 
American Journal of Physiology, 255, 525-530. 
Young, J., Weiss, J., & Boufath, N. (2002). Effects of rearing temperature on 
sympathoadrenal activity in young adult rats. Americal Journal of Physiology 
Regulatory, Integrative and Comparative Physiology, 283, 1198-1209. 
15 
 
CHAPTER 2 
Effects of Neonatal Immune System Activation with Lipopolysaccharide on Adolescent 
Anxiety Behaviours 
 
 
 
  
16 
 
2.1 Introduction 
Events occurring during development, such as early immune system activation can 
result in long term neurological and behavioural changes in adulthood. Administration of the 
endotoxin lipopolysaccharide (LPS) results in the stimulation of the immune and endocrine 
systems and the release of proinflammatory cytokines to produce physiological and 
behavioural symptoms known as the acute phase sickness response (Dantzer, 2001). This 
behavioural suite enables an organism to combat invading pathogens and increase likelihood 
of survival. For example, hyperthermia is an adaptive response that provides a hostile, 
antimicrobial environment for unwanted pathogens (Romanovskya & Székely, 1998) and 
reductions in food and water intake reduce the availability of nutrients, thereby preventing 
pathogen growth (Tenk, Kavaliers, & Ossenkopp, 2008). In addition, there is a sexual 
dimorphism in adult immune system function, with immune-enhancing effects of estrogen 
resulting in enhanced functioning in females (Gaillard & Spinedi, 1998).  
Recent studies have begun to explore the acute and long term effects of early immune 
activation in rats. Early neonatal exposure to LPS induces the same set of acute sickness 
responses in rat pups as seen in adulthood, including anorexia, hypoactivity, and activation of 
the HPA axis (Walker, Brogana, Roger, & Hodgson, 2004a; Dent, Smith, & Levine, 1999). 
Furthermore, consistent with adult findings, female rat pups exhibit greater HPA axis 
responses to an endotoxin challenge relative to males (Shanks, McCormick, & Meaney, 
1994).  
In order to activate the immune system during the neonatal period, the dual-exposure-
to-endotoxin (DEE) model is utilized, which involves the administration of LPS on postnatal 
days 3 and 5 (Spencer, Martin, Mouihate, & Pittman, 2006; Tenk, 2007). Results of several 
studies have shown a variety of physiological and behavioural changes in adulthood 
following neonatal immune system activation. For instance, neonatal LPS exposure has been 
shown to lead to to elevated IL–6 levels and increased susceptibility to periodontal disease in 
adulthood (Breivik, Stephan, Brabant, Straub, Pabst, & von Hörsten, 2002), as well as 
lowered natural killer cell activity in adult male rats (Hodgson, Knott, & Walker, 2001). 
However, LPS treatment on postnatal days 3 and 5 has also been shown to reduce 
inflammation and the development of arthritis in adulthood (Shanks, et al., 2000), as well as 
attenuate febrile response following adult endotoxin challenge (Walker, Hodyl, Krivanek, & 
Hodgson, 2006). 
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Anxiety is an affective state, characterized by heightened physiological and 
behavioural arousal in response to perceived or true threats (Gray & McNaughton, 2003). 
Such responses include increased blood pressure and heart rate, increased avoidance 
behaviour, and increased checking behaviour, which serves as risk assessment behaviours in 
potentially threatening situations (Misslin & Cigrang, 1986). These reactions are analogous 
in humans and animals, and as such, provide the potential to develop animal models to assess 
anxiety-related behaviour (Rodgers, Cao, Dalvi, & Holmes, 1997).  
Various rodent models of anxiety aim to induce a natural conflict situation, in which 
an animal is exposed to potential stressors such as a novel situation. The conflict arises 
between the tendency to avoid the unfamiliar (neophobia) and the tendency to explore a new 
environment (Bourin & Hascoet, 2003). Rodents have a proclivity toward dark, enclosed 
spaces, and an innate fear of open, well-lit areas (Walf & Frye, 2007). Thus, brightly 
illuminated areas and open spaces are appraised as potentially threatening situations and 
produce unconditioned aversive emotional reactions in rodents (Walsh & Cummins, 1976). 
Measures of anxiety-related behaviour are determined from this preference for dark areas, 
equated with protection and safety, with an animal’s natural tendency to remain in safe areas 
related to the level of anxiety (Crawley & Goodwin, 1980). Tests such as the elevated plus 
maze and the light-dark test consist of aversive, brightly lit areas (open arms and light 
chamber) and dark, enclosed areas (closed arms and dark chamber). Anxiety is measured as 
the duration of time spent avoiding illuminated areas and remaining in the dark areas. Both 
the elevated plus maze and light-dark test have been shown to be valid measures of anxiety. 
Time spent in the open arms and light chamber is reduced when rodents are given anxiogenic 
drugs, but increased with the use of anxiolytics meant to alleviate anxiety (Bourin & Hascoet, 
2003; Walf & Frye, 2007). 
Similarly, a novel environment produces an anxiety-provoking situation and often 
leads to defensive reactions, which may be in conflict with the desire for exploration (Misslin 
& Cigrang, 1986). A measure of locomotor activity in a novel environment such as the open-
field test is indicative of an animal’s level of anxiety, with reduced activity and greater 
freezing behaviour suggestive of greater anxiety. Furthermore, because the novel 
environment is aversive to rodents, thigmotaxis is often observed, where activity is confined 
to the periphery (Prut & Belzung, 2003). This tendency to avoid the center areas is part of a 
natural defence mechanism to avoid predators, as it is more difficult to attack a thigmotaxic 
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rodent than one out in the open (Treit & Fundytus, 1988). Thus, measures of locomotor 
activity and thigmotaxis behaviour are used as other indicators of anxiety-related behaviours, 
and have been shown to be valid measures due to their sensitivity to anxiogenic and 
anxiolytic drugs (Ramos, 2008; Treit & Fundytus, 1988; Misslin & Cigrang, 1986). 
Anxiety-related behaviour in rodents such as rats is modified by several factors, 
including developmental stage. Adolescence is a transitional developmental period between 
childhood and adulthood, during which animals undergo neurological and behavioural 
alterations (Spear, 2000). This developmental period encompasses a broad age range, which 
can begin shortly after weaning and last until early adulthood. Furthermore, these changes 
can vary depending on sex, with early adolescent onset occurring in female rats as early as 20 
days, and lasting until as late as day 55 in male rats (Spear, 2000). Most researchers often 
determine the adolescent period in rats to range from postnatal days 28–42, a conservative 
age range during which animals of both genders tend to exhibit adolescent-typical 
neurobehavioural characteristics (Spear, 2000). Research has indicated that typically 
developing adolescent rats show predominantly more risk-taking behaviour and less anxiety-
related behaviour than adults (Stansfield & Kirstein, 2006). This increase in sensation 
seeking associated with adolescence provides the opportunity to explore new situations and 
concurrent behaviours, necessary for appropriate development and maturation into adulthood 
(Spear, 2000). For example, adolescent animals have been shown to have greater novelty-
induced locomotor activity, greater preference for novel objects, and greater approach and 
exploratory behaviours as compared to adult animals (Stansfield & Kirstein, 2006). 
Additionally, anxiety measures, such as those observed in the elevated plus maze, tend to be 
less evident in adolescence compared to adulthood (Doremus, Varlinskaya, & Spear, 2004). 
For instance, adolescent male rats have been shown to exhibit less anxiety-like behaviour 
than adult males in the elevated plus maze (Schramm-Sapyta et al., 2007; Andrade et al., 
2003), the open-field test (Masur, Schutz, & Boerngen, 1980; Meyza, Boguszewski, Niko, & 
Zagrodzka, 2011), and the light-dark test (Schramm-Spyta et al., 2007). Similar results have 
been observed for females, with adolescent rats showing reduced anxiety in the elevated plus 
maze (Genn, Tucci, Thomas, Edwards, & File, 2003; Imhof, Coelho, Schmitt, Morato, & 
Carobrez, 1993) and open-field (Masur, Schutz, & Boerngen, 1980) compared to adults.  
Sex differences in anxiety-related behaviour have been found in both adult and 
adolescent rats, but are not always observed in a consistent direction. Adult female rats 
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(across the estrous cycle) have shown less anxiety-like behaviour than males in the elevated 
plus maze (Zimmerberg & Farley, 1993; Johnston & File, 1991) and the light-dark test 
(Hughes, Desmond, & Fisher, 2004). Furthermore, adult male show higher degree of anxiety-
like behaviour in the defensive withdrawal test compared to females (Romana & Arborelius, 
2009). In contrast, adult females show greater anxiety in a predator threat test (Meng & 
Drugant, 1993)-and open-field test (Meng & Drugant, 1993; Archer, 1975). There is some 
evidence of sexual dimorphism in adolescence. For example, female rats show less anxiety-
related behaviour than males during late adolescence in the open field (Masur, Schutz, & 
Boerngen, 1980) and the elevated plus maze (Genn et al., 2003; Imhof et al., 1993). 
However, such patterns vary across studies and developmental age, and there is a lack of 
evidence suggesting consistent sex differences in anxiety-related behaviour during 
adolescence. 
Given the purported anxiogenic effects of acute LPS exposure, it is of particular 
interest to examine the behavioural consequences of neonatal endotoxin exposure on anxiety-
related behaviours. Neonatal LPS administration has been shown to increase adult anxiety 
behaviour in the light-dark test (Lacosta, Merali, & Anisman, 1999) and elevated plus maze 
(Walker, March, & Hodgson, 2004b). Other findings have shown that early LPS exposure 
had no effect on anxiety-realted behaviours, such as activity in the open-field test (Breivik et 
al., 2002). Furthermore, very few studies to date have examined the influence of neonatal 
LPS on anxiety during adolescence. For instance, neonatal (DEE) LPS exposure was found 
to increase anxiety-related behaviours in the elevated plus maze in adulthood in male rats, 
but had no effect on anxiety in adolescence (Walker, March, & Hodgson, 2004b). Neonatal 
LPS treatment (DEE) has also been shown to reduce anxiety-related behaviours in the open-
field and elevated plus maze, and led to increased exploratory behaviour in response to 
novelty (Rico, Ferraz, Ramalho-Pinto, & Morato, 2010). These studies suggest that the 
effects of neonatal LPS on anxiety-related behaviours may be complex and may have varying 
effects at different developmental stages.  
Adolescence is a period of significant brain development, and early-life stress has 
long-term neurological and psychological consequences. Given the relatively small amount 
of research, as well as inconsistent results, the aims of the present study were to further 
investigate the effects of neonatal LPS exposure on anxiety-related behaviours in adolescent 
rats. The influence of neonatal LPS treatment using the DEE model on anxiety was analyzed 
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through observations from the elevated plus maze, open-field, and light dark tests. Given the 
scarcity of research examining the effects of neonatal LPS on adolescent anxiety-related 
behaviours, anxiety measures were collected during this critical period. Further examination 
of possible sex differences in anxiety responses, as well as possible interrelationships 
between variables were also considered. 
2.2 Methods 
2.2.1 Animals  
Eleven primiparous female Long-Evans rats weighing approximately 250-300 g were 
mated with male Long-Evans rats (300-400 g, Charles River, Canada) for a total of 11 litters. 
Females were paired with a male overnight the night prior to behavioural estrous, identified 
through vaginal smear. Sperm present on a vaginal smear (hematoxylin and eosin stain) the 
morning after pairing indicated successful mating and this was designated as gestational day 
0 (G 0). Dams were housed individually in standard polypropylene cages (45 x 22 x 20 cm) 
in a temperature-controlled colony room (21 ± 1 oC), and maintained on a 12:12 light – dark 
cycle with the lights on at 07:00 hours. Food (Prolab rat chow) and tap water were available 
ad libitum. Cages were checked daily until the birth of the pups and subjects were derived 
from a single litter from each dam. Litters (litter size ranged between 11 – 19 pups) were 
born on G 22 (designated as postnatal day (P) 0), toe-clipped for identification on P1, and 
were not culled until weaning at P 21 (M = 15.73 pups, SD = 2.24). On P21, pups were 
weaned and culled to a maximum of 8 animals/litter (4 males, 4 females). Following 
weaning, rats were pair-housed with same-sex, same-treatment littermates in standard 
polypropylene cages under the same conditions as dams, with behavioural testing beginning 
on postnatal day 38. Experimental manipulations were conducted during the light phase of 
the light – dark cycle. All procedures were approved by the University of Western Ontario 
Animal Care Committee and were in accordance with the Canadian Council of Animal Care 
(CC guidelines).  
2.2.2 Neonatal drug administration 
On postnatal days 3 and 5, rat pups were injected intraperitoneally (i.p.) using a 
Hamilton syringe with a 30 gauge needle tip. Within a litter, two pups of each sex were 
randomly assigned to each treatment condition. Treatment consisted of administration of 
either 50 µg/kg LPS (derived from Escherichia Coli stereotype 0111:B4, L26030, Sigma 
Chemical, St. Louis, MO, USA) dissolved in 0.9% isotonic saline (NaCl; 1 µL/g), or an 
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equivalent volume of 0.9% saline solution on each of the two postnatal days (male-LPS n = 
23; male-NaCl n = 23; female-LPS n = 21; female-NaCl n = 19). This dose and 
administration schedule follows a similar procedure to previous studies, and has shown it to 
induce long-lasting behavioural changes in adult rats (Shanks et al., 1995; Breivik et al., 
20002; Walker et al., 2004b; Tenk, 2007). During the injection procedure, the entire litter 
was removed from the home cage and placed under a heat-lamp for the duration of the 
injections, approximately 15 min per litter.  
2.2.3 Behavioural testing 
A maximum of 8 rats from each litter was put through the battery of tests (4 males – 2 
neonatal LPS, 2 neonatal NaCl; 4 females – 2 neonatal LPS, 2 neonatal NaCl per litter) 
beginning on postnatal day 38.  
2.2.3.1 Elevated plus maze (EPM). The EPM apparatus was made of wood and 
painted grey with washable paint. It consisted of two open arms (54 x 12 cm) with no sides 
or ends orthogonal to two opposed arms of the same size, enclosed with sides and ends (54 x 
12 x 48 cm). The apparatus was raised 50 cm above the floor, with the four arms extending 
from a center platform (12 x 12 cm). An overhead camera, connected to a television and 
DVD-R, recorded behaviour for later scoring. 
Testing took place on the afternoon of P 38. Animals were placed on the center 
platform facing an open arm to begin the test. Animals were allowed to freely explore while 
being recorded for 5 min. After each animal, the maze was cleaned with a 20% alcohol 
solution. 
Measures assessed included number of entries into open and closed arm and time 
spent (s) on open and closed arms. Percent time spent in open arms (time spent in open 
arms/time spent in open arms + time spent in closed arms x 100) was taken as a measure of 
anxiety. In addition, risk assessment behaviour was analyzed, as this provides an 
ethologically based assessment of anxiety; the more time an animal spends assessing the 
environment for potential danger, the more anxious the animal. Risk assessment was 
measured as: number of, and time spent (s) engaging in head stretch attends and body stretch 
attends (head stretching into open arms while forepaws and body remain in the closed arm or 
forelimbs exit the closed arm and body stretches into open arms while hindlimbs remain in 
the closed arm, respectively); head dips (head reaching downwards below arms towards the 
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floor); and double backs (exiting an arm with the forepaws and re-entering the same arm with 
the forepaws). 
2.2.3.2 Open-field apparatus. Locomotor activity in a novel open field was 
monitored using eight Versamax Animal Activity Monitors (AccuScan Model DCM-8, 
Columbus, OH, USA). Each apparatus consists of a Plexiglas open field chamber (40 cm x 
40 cm x 30.5 cm), a Plexiglas lid with air holes, and infrared beams surrounding the chamber 
to record horizontal and vertical locomotor movements as beam breaks (Ossenkopp & 
Kavaliers, 1996). There were 16 infrared beam sensors on each side (2.54 cm apart, 4.5 cm 
from the floor) to measure horizontal movements, and 16 upper beams located 15 cm above 
the chamber floor on two opposite sides to measure vertical movements. Additionally, the 
VersaMax software separated the open-field into discrete periphery (7.5 cm wide border) and 
center (30 x 30 cm square) zones to measure thigmotaxis (tendency of animals to stay close 
to the walls, an indication of anxiety). 
Animals were placed in the open-field for 60 min (6 - 10 min time bins) on P 39, 
which was measured as baseline to a novel environment, and P 40 to assess locomotor 
activity in the now familiar open field. Horizontal activity measures analyzed were: total 
distance (TD) − total horizontal distance (cm); horizontal movement time (MT) − amount of 
time (s) an animal was engaged in horizontal movement; number of horizontal movements 
(NM) − number of horizontal movements separated by 1 s stop time. The vertical activity 
measure analyzed were: the number of vertical movements (VM) − number of vertical 
movements separated by 1 s stop time; vertical movement time (VT) – amount of time (s) an 
animal spent in a vertical position. Number of entries and duration of time spent in the 
periphery and center (horizontal and vertical movements) were also recorded. 
2.2.3.3 Light-dark apparatus. A black Plexiglas box (40 cm x 20 cm x 30 cm) was 
inserted into each VersaMax Animal Activity Monitor, dividing the open-field into two equal 
size chambers; a “dark” chamber and a “light” chamber. The sides of the black insert 
contained small holes to prevent obstruction of the photo-beams. Animals were allowed 
unrestricted access though a 10 x 8.5 cm doorway centered along the insert wall. Animals 
were placed in the center of the light region and allowed to move freely between the two 
compartments for 30 min on P 41. Time spent in the light and dark chambers (duration; s) 
was analyzed, as well as number of entries into each chamber (entries), defined as a beam 
break once an animal moves its head through the chamber doorway. Locomotor activity was 
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assessed (TD, VM, VT) in both the light and dark chambers and was corrected for time spent 
in the corresponding chamber.  
2.2.4 Procedure 
As previously described, 4 male and 4 female pups from each litter were given i.p. 
injections of either LPS or saline on P 3 and P 5 of birth. The developmental milestone of eye 
opening was monitored on P 12-16 and pups were weaned on P 21. Body weight was 
monitored on injection days, and measured weekly throughout the testing process, as well as 
each day of behavioural testing. Behavioural testing occurred during adolescence (postnatal 
days 38-41). See Figure 2.1 for a timeline of the behavioural procedure. 
On P 38 animals were placed in the elevated plus maze and recorded for 5 min. 
Animals were monitored in the open-field apparatus on P 39 for 60 min in order to habituate 
them to a novel environment, and then again on P 40 to assess any changes in locomotor 
activity. Finally, animals were placed in the light-dark apparatus on P 41 for 30 min in order 
to measure anxiety based on preference for dark places. Animals were left undisturbed 
following the final testing day, with the exception of body weight measurement once weekly. 
2.2.5 Statistical analysis 
All analyses were performed with IBM SPSS Statistics 19 (formerly PASW Statistics 
18). Significance was set to α = .05. 
2.2.5.1 Eye opening. Eye opening was analyzed using a mixed design (split plot) 
analysis of variance (ANOVA), with the between subjects factors of Sex, Neonatal Drug (2 
levels: LPS, NaCl), and Litter (11 levels), and the within subjects factor of Day (5 levels). 
Where appropriate, LSD post-hoc comparisons were performed. 
2.2.5.2 Elevated plus maze (EPM). EPM data were analyzed using a multivariate 
analysis of variance (MANOVA), with the between subjects factors of Sex, Neonatal 
Treatment (2 levels: LPS, NaCl), and Litter (11 levels). Post-hoc comparisons of significant 
effects were performed where appropriate using LSD test. 
2.2.5.3 Open-field, thigmotaxis, and light-dark tests. Behavioural data collected 
during the open-field, thigmotaxis, and light-dark tests were analyzed using a mixed design 
(split-plot) analysis of variance (ANOVA) with between-subjects factors of Sex (2 levels: 
male and female), Neonatal Treatment (2 levels: LPS or saline) and Litter (11 levels). The 
within subjects factors were Day and/or Time, which varied depending on the behavioural 
test being analyzed. For the open-field and thigmotaxis tests, there were 2 levels of Day and  
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6 levels of Time (6, 10-min time bins). For the thigmotaxis test, another within-subjects 
factor was Area (2 levels: perimeter and center). For the light-dark tests, only a within 
subjects factor of Time was considered (6 levels of 5-min time bins). Post-hoc comparisons 
of significant main effects and interactions were performed using LSD test when appropriate. 
2.3 Results 
2.3.1 Eye Opening 
All animals showed normal eye opening patterns during development, with one or 
both eyes opening between postnatal days 12–16. There were no effects of neonatal LPS 
exposure on eye opening, as no significant delays were observed between treatment groups, 
F(1, 43) = .95, p = .344. Additionally, both males and females showed similar eye opening 
patterns, indicating no evidence of a sex difference, F(1, 43) = 1.04, p = .341, and no 
significant interaction was observed. Thus, it can be concluded that neonatal LPS 
administration did not have a significant effect on development in terms of the appropriate 
developmental milestone of eye opening. 
2.3.2 Elevated Plus Maze 
Due to the presence of outliers, eight animals were excluded from the analyses of the 
various behavioural measures (2 male-NaCl, 2 male-LPS, 1 female-NaCl, 3 female-LPS 
animals excluded). Statistical analysis did not reveal any effects of Sex for measures of 
anxiety in the elevated plus maze, as no significant differences between female and male 
groups were found in the number of entries into the open and closed arms, and the amount of 
time spent in the closed arms of the maze. However, a main effect of Drug was observed, 
F(1, 37) = 6.24, p = .017, with the vehicle animals showing a greater percent time in open 
arms than the LPS animals (see Figure 2.2). Additionally, no effects of sex or drug were 
found in the various risk assessment behaviours, inclusive of head and body stretch attends, 
head dips, and double backs. The MANOVA did not yield any Sex x Neonatal Treatment 
Interactions for any of the measures of anxiety in adolescence. For a summary of significance 
data see Appendix A. 
A significant main effect of Litter was found for several of the EPM variables 
including the number of open entries (F(10, 37) = 4.30, p =.001), the number of closed arm 
re-entries (F(10, 37) = 2.67, p =.014), the number of head stretch attends (F(10, 37) = 4.66, p 
< .001), duration of head stretch attends (F(10, 37) = 2.50, p =.021), number of body stretch 
attends (F(10, 37) = 9.60, p < .001), and duration of body stretch attends (F(10, 37) = 14.12,  
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Fig. 2.2 Group mean (± S.E.M.) percent time in open arms of the elevated plus maze (time 
spent in open arms/time spent in open arms + time spent in closed arms x 100) during 
adolescence (P 38). * p < .05 indicates a significant overall neonatal drug effect, neonatal 
saline animals (n = 39) had greater percent time in open arms than neonatal LPS animals (n = 
39) (male-SAL: n = 21, male-LPS: n = 21, female-SAL: n = 18, female-LPS: n = 18).  
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p < .001). These results highlight the importance of accounting for inter-litter variance (post 
hoc tests not reported).  
2.3.3 Open Field: Overall Activity Levels 
Representative measures of overall horizontal and vertical activity during adolescence 
are depicted in Figure 2.3A-C. Statistical analysis of these data suggests no significant effects 
of Sex or Neonatal Treatment in total distance, movement time, number of horizontal 
movements, or number of vertical movements. A significant main effect of Litter was found 
on Day 39 for all variables inclusive of total distance, F(10, 43) = 8.87, p < .001, total 
movement time, F(10, 43) = 10.28, p < .001, total number of horizontal movements, F(10, 
43) = 9.67, p < .001, and total number of vertical movements F(10, 43) = 25.16, p < .001 
(post hoc tests not reported). Similar Litter effects were observed on Day 40.  
Habituation was demonstrated for all animals across time and day, as the overall 
activity level decreased over the 60 min time period, and was reduced on day 40 as compared 
to day 39. For a summary of significance data see Appendix B.  
2.3.4 Open Field: Thigmotaxis Behaviours 
Representative measures of horizontal activity (duration), vertical activity (vertical 
time) and number of entries in periphery and center zones on days 39 and 40 are depicted in 
Figure 2.4A-C. No significant differences were found between Sex and Neonatal treatment 
groups for any of the measures. For a summary of significance data see Appendix C. All 
animals travelled more, and spent greater time in the periphery than in the center areas, 
demonstrating consistent thigmotaxis behaviour across groups. Habituation to the open-field 
was demonstrated for all animals across time and day, as number of entries and overall 
horizontal and vertical activity levels decreased over the 60 min time period and from day 39 
to day 40 (main effect of day and main effect of time, p < .001 for all behavioural measures).  
A main effect of Litter was found for all representative measures of thigmotaxic behaviour 
(statistics not reported), emphasizing the importance of parsing out inter-litter variance in the 
ANOVA.  
2.3.5 Light-Dark Test 
One female-NaCl animal was excluded from this analysis due to technical difficulties 
in obtaining data. A representative measure of horizontal activity (total distance, cm/min; 
duration, s) and vertical activity (total number of vertical movements, cm/min; total vertical 
movement time, cm/min) in both chambers is depicted in Figure 2.5A-D. The  
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Fig. 2.3 Group mean (± S.E.M.) horizontal and vertical locomotor activity measures in the 
novel (P 39) and familiar open field (P 40) during adolescence. (A) total distance travelled in 
cm (B) movement time in s (C) number of vertical movements. * p < .05 (male-SAL: n = 23, 
male-LPS: n = 23, female-SAL: n = 19, female-LPS: n = 21). 
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Fig. 2.4 Group mean (± S.E.M.) thigmotaxis behavioural measures in the novel (P 39) and 
familiar open field (P 40) during adolescence. (A) duration in periphery and center areas in s 
(B) vertical time in periphery and center areas in s (C) number of entries in periphery and 
center areas. Horizontal lines represent the point at which equal time would be expected to be 
spent in each area. * p < .05 (male-SAL: n = 23, male-LPS: n = 23, female-SAL: n = 19, 
female-LPS: n = 21).  
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Fig. 2.5. Group mean (± S.E.M.) activity behaviours in the light-dark test during adolescence 
(P41). (A) corrected total distance (cm travelled per min) in light and dark chambers (B) total 
duration (s) spent in light and dark chambers (C) corrected number of vertical movements  
(cm per min) in light and dark chambers (D) corrected vertical time (cm per min) in light and 
dark chambers. Horizontal lines represent the point at which equal time would be expected to 
be spent in each chamber. *p < .05 indicates significant Neonatal Drug x Sex interaction. 
Male-LPS animals had a greater number of vertical movements than male-NaCl animals in 
the light chamber. ‘a’ indicates a significant main effect of chamber (p < .05) with all 
treatment groups spending more time in the dark chamber. ‘b’ indicates a significant main 
effect of chamber (p < .05) with all treatment groups travelling more, having greater number 
of vertical movements and greater vertical time in the light chamber (male-SAL: n = 23, 
male-LPS: n = 23, female-SAL: n = 18, female-LPS: n = 21). 
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ANOVA conducted on these data yielded no significant interactions or main effects for 
measures of horizontal activity in either the light or dark chambers. A significant Sex x 
Neonatal Drug interaction was observed for the total number of vertical movements in the 
dark chamber, F(1, 42) = 5.95, p =.019, with male LPS animals demonstrating a greater 
number of vertical movements than male NaCl animals (p = .017). No significant effects 
were observed for total duration of vertical movements. There were no differences between 
the sexes or neonatal treatment groups in the number of entries into the light or dark 
chambers. For a summary of significance data see Appendix D.  
A main effect of Chamber was observed for all animals across the various activity 
measures. All animals showed greater total distance in the light chamber, F(1, 42) = 122.72, 
p < .001. A main effect of Chamber was observed for Duration, F(1, 42) = 197.83, p < .001, 
as all animals spent more time in the dark chamber as compared to the light chamber. As 
well, animals showed a greater amount of vertical activity in the light chamber, as compared 
to the dark chamber. All animals demonstrated a greater number of vertical movements, F(1, 
42) = 238.65, p < .001, and greater duration of vertical movements, F(1, 42) = 108.54, p < 
.001, in the light chamber.  
Finally, all animals entered the light chamber more often than the dark chamber, F(1, 
42) = 35.66, p < .001. Analysis revealed a main effect of Time for number of entries in the 
light chamber (F(4, 155) = 160.43, p  < .001) and dark chamber (F(3, 135) = 76.04, p  < 
.001), as well as duration into the light (F(3, 139) = 48.34, p < .001) and dark (F(3, 132) = 
37.16, p < .001) chambers. Thus, all animals demonstrated habituation to the environment, as 
the number of entries into the chambers decreased over the 30 min period. Additionally, a 
main effect of Litter was observed for several variables in the dark chamber, inclusive of 
number of entries (F(10, 42) = 3.26, p =.003), total distance (F(10, 42) = 2.53, p =.017), total 
number of vertical movements (F(10, 42) = 8.75, p <.001), and total duration of vertical 
movements (F(10, 42) = 3.26, p =.003). Finally, a main effect of Litter was observed for the 
number of entries into the light chamber, F(10, 42) = 19.70, p <.001 (post hoc tests not 
reported).  
2.4 Individual Differences Analysis 
Given the within-litter differences observed in the statistically analyses, individual 
differences were examined. In order to assess the validity of the various behavioural tests of 
anxiety, Pearson correlations were conducted between variables within a test for each 
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treatment group. Furthermore, Pearson correlations were also conducted to examine 
differences in behavioural measures between the various tests of anxiety. 
2.4.1 Correlations Within Tests 
2.4.1.1 Elevated plus maze correlation results. Pearson correlation analysis 
revealed several significant correlations between the classic measures of anxiety. 
Specifically, the number of open entries was significantly correlated with the percent time in 
open arms for all treatment groups (ps < .01), as well as negatively correlated with the 
duration in the closed arms for all groups (ps < .01). In addition, the duration in the closed 
arms was negatively correlated with percent time in open arms across sex and neonatal 
treatment groups (ps < . 01). These patterns of results indicate that duration in the closed 
arms decreased as animals entered and spent more time in the open arms. 
Significant correlations were also observed for various risk assessment behaviours, 
particularly the number of body stretch attends, which correlated highly with many of the 
classic variables. More specifically, the number of body stretch attends was positively 
correlated with the number of open arm entries (for treatment groups: female-LPS, female-
NaCl, and male-LPS), the number of closed arm entries (for treatment group: female-LPS, 
female-NaCl, and male-NaCl) and percent time in open arms (for treatment groups: female-
LPS, female-NaCl, and male-LPS). This general pattern is suggestive of greater risk 
assessment behaviour as an animal moves to various parts of the maze, but also highlights 
that such behaviours vary between individuals. Additionally, the number of body stretch 
attends correlated highly with the duration of body stretch attends (ps < .01), and a similar 
pattern of significant correlations was observed between number and duration of head stretch 
attends (ps < .01).  
The significant relationships between classic EMP variables demonstrate validity and 
suggest that a similar construct of anxiety is measured within the test. Furthermore, certain 
risk assessment variables, such as body stretch attends correlate highly with the classic EMP 
variables, while others, such as the number of closed arm re-entries (double backs) did not 
correlate with any of the other measures. This finding suggests that while a variable may 
seem to indicate a particular behaviour, this may not always be the case, and emphasizes the 
importance of examining these relationships. Finally, the correlation analyses show that all 
treatment groups generally demonstrate similar patterns of relationships. However, there are 
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some important individual differences across various measures of the same construct. For a 
summary of the correlations see Appendix J.  
2.4.1.2 Open field and thigmotaxis correlation results. Convergent validity was 
demonstrated for variables in the open field. Pearson correlation analysis yielded significant 
positive correlations between all five locomotor activity variables, inclusive of total distance, 
duration of horizontal movements, number of horizontal movements, number of vertical 
movements, and duration of vertical movements (ps < .01). These correlations were observed 
in both the novel and familiar open field and across sex and neonatal drug treatment groups, 
suggesting high validity of these measures. For a summary of the correlations see Appendix 
K1 and K2. 
Furthermore, significant correlations were observed for the various thigmotaxis 
behaviours in the open field. For both the novel and familiar open field, the number of entries 
into the center was positively correlated with duration of vertical movements in periphery (ps 
< .01) for all treatment groups. However, different patterns were observed for the duration of 
time in the periphery on each of the test days. For the novel open field, duration in periphery 
only correlated with the number of center entries for the female-saline and male-LPS groups 
(ps < .05), and was only significantly correlated with the duration of vertical movements in 
the periphery for the female-saline group (ps < .05). In the familiar open field, periphery 
duration correlated significantly with the number of entries into the center area for both male 
treatment groups (ps < .05), and with duration of vertical movements in the periphery for all 
treatment groups except the female-saline animals. For a summary of the correlations see 
Appendix L1 and L2. It should be noted that in the center areas in both the novel and familiar 
open field, all variables correlated significantly with all other variables across both sex and 
neonatal drug treatment (ps < .01). These results emphasize the importance of considering 
individual differences within treatment groups when measuring constructs such as anxiety-
related behaviours. 
The results of these analyses suggest that while there are similar patterns of 
significant relationships between the number of center area entries and duration of vertical 
movements in the periphery for all treatment groups, individual differences appear when 
examining the duration of time spent in the periphery in the novel and familiar open field. 
Overall, these findings suggest that despite measuring behaviour in a similar area of the 
environment, variables may be measuring different behaviours. For instance, duration in the 
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periphery may be measuring general anxiety, whereas vertical time may be indicative of 
escape behaviours, and these may be related in some, but not all, treatment groups.  
2.4.1.3 Light-dark test correlation results. For a summary of the correlations 
between light-dark test variables, see Appendix M. Pearson correlation analysis revealed 
significant correlations between behavioural measures in the light-dark test. Within the light 
chamber, analysis yielded strong negative correlations between duration and total distance, 
number of vertical movements, and duration of vertical movements (ps < .05). These 
significant correlations were observed for all treatment groups, with the exception of the 
female-saline animals for total distance and number of vertical movements. Such a pattern is 
expected, as animals move significantly less the more time they spend in a chamber. 
Additionally, total distance was significantly correlated with the number of vertical 
movements for all treatment groups, highlighting the relationship between two variables 
measuring similar constructs of movement. Furthermore, the number and duration of vertical 
movements in the light chamber were positively correlated for all treatment groups, 
emphasizing the validity of these behaviours in measuring the same construct.  
In the dark chamber, the number of entries was negatively correlated with the 
duration of time spent in the dark chamber (ps < .05) for all treatment groups, and positively 
correlated with total distance travelled in the dark chamber for both female treatment groups 
and male-LPS animals (ps < .05). Furthermore, total distance was negatively correlated with 
duration for all treatment groups, and positively correlated with the number of vertical 
movements for all groups except the female-LPS animals. Finally, the number and duration 
of vertical movements in the dark chamber were positively correlated for all treatment 
groups, similar to the correlations observed in the light chamber. 
Several significant correlations were also observed between the light and dark 
chambers. Duration in the light chamber was negatively correlated with duration in the dark 
chamber for all treatment groups (ps < .01). Furthermore, duration in the light chamber was 
positively correlated with number of entries and total distance in the dark chamber for all 
groups (ps < .01), suggesting that animals made a greater number of entries and travelled 
more in the dark chamber as the time spent in the light chamber increased. Finally, 
significant negative correlations were observed between the number of vertical movements in 
the light chamber and the number of entries (ps < .05) and total distance (ps < .05) in the dark 
chamber, indicated that as animals showed more vertical movements in the light chamber, 
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they had fewer entries and travelled less in the dark chamber. Such behaviour may be 
indicated of greater escape behaviour in the light chamber, which could not be accomplished 
in the dark chamber. However, a positive correlation was observed between the number of 
vertical movements in the light chamber and duration in the dark chamber for all groups with 
the exception of the female-saline animals. Thus, as escape behaviour increased through a 
greater number of vertical movements, duration in the dark chamber also increased, 
suggesting that when escape is not possible, hiding in the dark chamber increases. 
Overall, there are many significant relationships between variables within and across 
the light and dark chambers. This emphasizes the validity of the light-dark test and the 
behavioural measures used as indicators of anxiety. However, differences between treatment 
groups in these relationships are evident.   
2.4.2 Correlations Across Tests 
2.4.2.1 Novel open field compared to familiar open field. Pearson correlation 
analysis yielded many significant correlations between locomotor activity variables in the 
novel and familiar open field. For all treatment groups, total distance, number and duration of 
horizontal movements, and number of vertical movements in the novel open field correlated 
positively with the same variables in the familiar open field (ps < .01). For instance, a 
significant correlation was found between total distance in the novel open field and in the 
familiar open field for all sex and neonatal treatment groups. These findings suggest strong 
temporal consistency. Furthermore, significant positive correlations were observed between 
these variables on the two test days. For example, a significant correlation was found 
between total distance in the novel open field and the duration of horizontal movements in 
the familiar open field, suggestive of similar behaviour patterns on both test days. For the 
duration of vertical movements, similar patterns were observed, although not for all treatment 
groups. The results suggest similar patterns of behaviour in both the novel and familiar open 
field, although some variance in these relationships was evident between treatment groups.  
2.4.2.2 Thigmotaxis in novel open field compared to thigmotaxis in familiar open 
field. Significant correlations were observed for the various thigmotaxis behaviours between 
the novel and familiar open field. Duration in periphery, vertical time in periphery and 
number of entries into the center area in the novel open field all correlated significantly with 
their familiar open field variable equivalent (ps < .01). Furthermore, the number of entries 
into the center was positively correlated with duration of vertical movements in periphery (ps 
36 
 
< .01) across both the novel and familiar open fields. These results were observed for all 
treatment groups. However, different patterns were observed for the duration of time in the 
periphery. Male treatment groups showed significant correlations between duration in the 
periphery and number of center area entries between both test days (ps < .05). A similar 
pattern was observed for male-LPS animals between duration and vertical time in the 
periphery across the novel and familiar open fields. These correlations were not found to the 
same extent with the female animals.  
Overall the results suggest temporal consistency, as behaviours observed in the novel 
open field were significantly correlated with those in the familiar open field for all treatment 
groups. Similar to the results observed within tests, similar patterns of relationships were 
found between the number of entries into the center area and the duration of vertical 
movements in the periphery. However, duration in the periphery may better allow for 
individual differences to be detected, as different patterns of relationships were observed 
across sex and neonatal treatment groups.  
2.4.2.3 Novel open field compared to thigmotaxis in novel open field. Significant 
positive correlations were observed for the female groups and the male-NaCl group between 
the vertical time in the periphery and the locomotor activity variables (ps < .05). Moreover, 
the male animals and the female-LPS animals showed significant correlations between the 
number of center area entries and the locomotor variables. However, there were almost no 
significant correlations between duration in the periphery and any of the locomotor variables 
in the novel open field. These differences in results highlight the importance of examining 
individual differences in the variables across a battery of tests and suggest that indices of 
activity may be measuring different behavioural constructs. For instance, thigmotaxis may be 
an index of anxiety as measured by duration in the periphery, whereas locomotor activity 
may suggest exploration and/or escape behaviour. 
2.4.2.4 Novel open field compared to thigmotaxis in familiar open field. 
Correlation analysis of locomotor activity variables in the novel open field with thigmotaxis 
variables in the familiar open field showed that vertical time in the periphery did not 
significantly relate to any of the locomotor variables. Similar results were found for the 
duration in periphery, although a single positive correlation was found between total distance 
in novel open field and duration in periphery of familiar open field found for female-NaCl 
animals. However, number of entries into the center area was significantly correlated with all 
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locomotor variables from the female-LPS and male-NaCl animals. This finding provides 
evidence for relationships between various exploratory behaviours in novel and familiar 
environments. 
2.4.2.5 Familiar open field compared to thigmotaxis in familiar open field. 
Similar to the analysis between novel open field and thigmotaxis variables, no significant 
correlations were found between duration in the periphery of the familiar open field and any 
of the locomotor variables. Vertical time in the periphery was significantly correlated with all 
locomotor variables for female-LPS animals, and a similar pattern was observed between 
number of center area entries and locomotor activity (ps < .05). Male animals showed 
significant correlations between several open field and thigmotaxis variables, particularly the 
male-NaCl animals. Overall, the results suggest that various indices of activity in the open 
field may be measuring different behavioural constructs, and these relationships may change 
depending on sex and neonatal treatment. 
2.4.2.6 Familiar open field compared to thigmotaxis in novel open field. Contrary 
to findings in comparisons between locomotor variables in the novel open field and 
thigmotaxis behaviours in the familiar open field, different patterns of correlations were 
found for the familiar open field and thigmotaxis variables in the novel open field. Duration 
in the periphery in the novel open field did not yield significant correlations with any of the 
locomotor variables in the familiar open field. However, female-LPS and male-NaCl animals 
showed significant positive correlations between locomotor variables and vertical time in the 
periphery, as well as number of center area entries. These findings suggest relationships 
between exploratory behaviours that may vary depending on the novelty of the environment 
and behaviours assessed.   
2.4.2.7 Elevated plus maze compared to novel open field. When the variables from 
the elevated plus maze were compared with those from the novel open field, only a few 
significant correlations emerged and these varied depending on the treatment group. 
Significant positive correlations were observed for the female-LPS animals between the 
number of entries into the open arm and total distance in the open field (r = .44, p < .01) as 
well as the number of vertical movements (r =. 47, p < .01). This suggests that some 
exploratory behaviour in the elevated plus maze correlates with exploratory behaviour in the 
novel open field for the females treated with neonatal LPS. Conversely, open arm entries 
may indicate checking behaviour, which correlates positively with the number of vertical 
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movements indicative of escape behaviour. Males treated neonatally with LPS show 
significant negative correlations between the number of head stretch attends in the EMP and 
the number of vertical movements in the novel open field (r = -.56, p < .01), as well as the 
duration of vertical movements (r = -.43, p < .05). Similarly, a significant negative 
correlation was observed between the number of head stretch attends in the EMP and the 
number of vertical movements in the novel open field for the female-saline animals (r =  -.57, 
p < .01). These results suggest that as risk assessment behaviour in the elevated plus maze 
increase, the number and duration of vertical movements in the open field decrease. Taken 
together, the few correlations between the behaviours in the elevated plus maze and those in 
the novel open field suggest that these two tests may measure different constructs of anxiety.  
2.4.2.8 Elevated plus maze compared to thigmotaxis in novel open field. Pearson 
correlation analysis yielded significant correlations between variables in the elevated plus 
maze and thigmotaxis behaviours in the novel open field. Specifically, negative correlations 
were found for all treatment groups between the number and duration of body stretch attends 
and the duration in the periphery of the novel open field (ps < .05). This suggests that as 
typical thigmotaxis behaviour increases, checking/risk assessment behaviour decreases. A 
similar pattern emerged for males, particularly the male-LPS animals, with the number and 
duration of head stretch attends negatively correlating with the number of center area entries. 
This result indicates that risk assessment behaviour increases with decreases in entries into 
the center area.  
2.4.2.9 Elevated plus maze compared to familiar open field. A pattern of 
correlations between variables in the elevated plus maze and the familiar open field emerged 
for some of the treatment groups. Specifically, as anxiety behaviour in the elevated plus maze 
increased, locomotor activity in the familiar open field decreased, particularly in the male-
LPS and female-NaCl animals. These results were observed between the duration of time in 
the closed arms, the number of closed arm re-entries and head stretch attend behaviours and 
the various locomotor variables. For example, a significant negative correlation was observed 
between the number of closed arm re-entries and the duration of horizontal movements (r = -
.53, p < .01) for male-LPS animals. The negative correlation suggests behavioural 
consistency between tests, where freezing behaviour, or the decline in locomotor activity, is 
related to risk assessment and anxiety-related behaviours in the elevated plus maze. This 
pattern was not observed for the female-LPS animals, but rather significant positive 
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correlations were observed between the number of closed arm entries and total distance (r = 
.46, p < .05), as well as the number of horizontal movements (r = .49, p < .05). This suggests 
that anxiety behaviour in the elevated plus maze is correlated with increases in locomotor 
activity for female-LPS animals. Overall, the results highlight the importance of examining 
individual differences between treatment groups, as the sex and neonatal treatment groups 
demonstrated different patterns of relationships between EPM and locomotor variables.  
2.4.2.10 Elevated plus maze compared to thigmotaxis in familiar open field. A 
pattern of significant negative correlations was observed between duration in the periphery of 
the familiar open field ad the number and duration of body stretch attends. These results were 
observed for all treatment groups, and suggest that as thigmotaxis behaviour increases, risk 
assessment behaviour decreases. Similar patterns were observed for head stretch attend 
behaviours for both male treatment groups, with significant negative correlations with 
duration and vertical time in periphery. Furthermore, males show significant negative 
correlations between number and duration of head stretch attends and number of entries into 
the center. Finally, females show a significant positive correlation between the number of 
open arm entries and the number of entries into the center area. These results are suggestive 
of similar anxiety-like behaviour, as well as common exploratory behaviour across tests. 
2.4.2.11 Elevated plus maze compared to light-dark tests. Very few correlations 
were observed between variables in the elevated plus maze and light-dark tests. Furthermore, 
the analysis yielded different correlations for each treatment group. For instance, a significant 
negative correlation was observed between the number of closed arm entries in the EMP and 
the number of vertical movements in the dark chamber for females treated with LPS (r = -
.55, p < .05). Generally, body stretch attends were correlated with duration and total distance 
in the light and dark chambers for female groups, whereas for male groups, head stretch 
attends were correlated with these variables in the dark chamber only. Finally, the number of 
head stretch attends was negatively correlated with the number of entries into the light 
chamber for LPS-males only (r = -.58, p < .01). This finding suggests that an increase in risk 
assessment is associated with a decrease in anti-anxiety behaviour. The small number of 
correlations between the EMP and light-dark test may suggest a lack of behavioural 
consistency across tests, or possibly that the two tests measure different constructs of anxiety.  
2.4.2.12 Light-dark test compared to novel open field. Pearson correlation analysis 
yielded several patterns of significant correlations between variables in the light-dark test and 
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the novel open field. For males treated with LPS or saline control, entries into the light 
chamber correlated significantly with all locomotor variables in the novel open field, 
inclusive of total distance, number and duration of horizontal movements, and number and 
duration of vertical movements (ps < .05). The same pattern of correlations was observed for 
entries into the dark chamber for both groups of males (ps < .05). Furthermore, similar 
correlations were observed for females treated with saline, with entries into the light chamber 
correlating with all locomotor variables, and entries into the dark chamber correlating 
significantly with some, but not all, of these variables (total distance, number and duration of 
horizontal movements). LPS-females showed significant correlations only between entries 
into the light chamber and the number of vertical movements (r = .51, p < .05), as well as 
vertical time in the light chamber and vertical time in the novel open field (r = .46, p < .05). 
Taken together, these findings suggest behavioural consistency across these tests for some 
groups, particularly the males regardless of neonatal treatment.  
2.4.2.13 Light-dark test compared to thigmotaxis in novel open field. Very few 
significant correlations were observed between variables in the light-dark test and 
thigmotaxis behaviours in the novel open field. However, several significant correlations 
emerged for the different treatment groups. For instance, duration in the periphery was 
positively correlated with entries into the dark chamber and total distance in the dark 
chamber, and negatively correlated with total distance in the light chamber. These results 
suggest that anxiety-related behaviours between tests are related. Male, but not female, 
animals show significant positive correlations between the number of entries into the light 
chamber and the number of entries into the center, suggestive of checking and exploratory 
behaviour. Furthermore, a significant correlation was also found between the number of 
entries into the light chamber and the duration of vertical movements in the periphery for 
male-LPS animals, indicative of similar escape behaviours. Taken together, these results 
suggest similar patterns of anxiety and exploratory behaviours between the measures of the 
light-dark and novel thigmotaxis tests.   
2.4.2.14 Light-dark test compared to familiar open field. Pearson correlation 
analysis yielded several significant correlations between variables in the light-dark test and 
the familiar open field. Entries into the light chamber correlated with all locomotor variables 
for male-NaCl animals (total distance, number and duration of horizontal movements, and 
number and duration of vertical movements), as well all locomotor variables for female-NaCl 
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animals with the exception of duration of vertical movements (ps < .05). However, for the 
female-LPS animals, a significant correlation was only observed between number of entries 
into the light chamber and number of vertical movements (r = .47, p < .05). Furthermore, a 
similar result was observed for male-LPS animals, with number of entries into the light 
chamber correlating with the number (r = .63, p < .01) and duration (r = .46, p < .05) of 
vertical movements in the familiar open field. These results suggest that the LPS treated 
animals demonstrated behavioural consistency between measure of escape (vertical 
movements) and checking behaviour (entries into the light chamber). Finally, for the male-
saline animals only, significant negative correlations were observed between duration in the 
dark chamber and locomotor activity variables in the familiar open field, suggesting that as 
duration in the dark chamber increase, locomotor activity in the open field decreased. These 
findings highlight the necessity of examining individual differences, as the male-saline 
animals showed far greater number of correlations than the other treatment groups. 
Furthermore, they emphasize the importance of understanding how different tests can assess 
various aspects of the same construct.  
2.4.2.15 Light-dark test compared to thigmotaxis in familiar open field. Similar 
to thigmotaxis behaviours in the novel open field, the Pearson analysis yielded very few 
correlations between measures in the light-dark tests and thigmotaxis behaviours in the 
familiar open field. Significant results were observed for the female-LPS animals. For 
instance, positive correlations were found between duration in the periphery and entries in 
the dark chamber, as well as total distance in the dark chamber (ps < .05). Furthermore, 
female-LPS animals showed negative correlation between duration in the periphery and total 
distance in the light chamber. These results suggest that anxiety-like behaviours are similar 
across tests. Female-LPS animals also demonstrated a significant positive correlation 
between duration in periphery of the familiar open field and duration in the light chamber. 
This result may suggest that the familiar open field measures different aspects of anxiety than 
the novel light-dark test. Finally, male-NaCl animals showed similar patterns of exploratory 
and escape behaviour between the tests, with the number of entries into the light chamber 
correlating with number of entries into the center area and vertical time in the periphery. 
Taken together, these results suggest that the tests may measure similar constructs of anxiety, 
but also highlight the unique aspects produced by each test.  
2.4.3 Conclusions 
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There are clear relationships between variables both within and across tests of 
anxiety-related behaviours. As such, it is important to examine these relationships, as they 
promote a better understanding of the different constructs of anxiety that are found across 
tests. Overall, the correlation analyses within the various tests suggest that the elevated plus 
maze, open-field, and light-dark tests are reliable measures, in that the variables within a test 
appear to show many significant relationships. However, different patterns of relationships 
emerged between the sex and neonatal drug treatment groups, highlighting the role of 
individual differences in altering behavioural observations of well-established variables. For 
instance, males treated neonatally with saline and female treated neonatally with LPS showed 
the greatest number of significant correlations between tests. However, the patterns of 
relationships vary depending on the tests being examined. This may suggest that neonatal 
treatment may have sex-specific effects on activity and anxiety-related behaviours, although 
these specific effects remain unclear. 
Furthermore, analyses between tests show that the various tests may be assessing 
different aspects of anxiety. While these correlations are generally informative, to gain a 
better understanding of these relationships, factor analysis should be conducted. In this way, 
the large number of variables both within and across tests may be reduced to a small number 
of underlying dimensions of anxiety. Using factor analysis will allow for a better 
understanding of the constructs of anxiety being measured from each individual test.  
2.5 Discussion 
 The current study examined the effects of neonatal LPS exposure on anxiety-related 
behaviour in male and female adolescents, as well as potential sex differences in these 
effects. The findings of this study suggest that LPS treatment on postnatal days 3 and 5 may 
have highly specific effects on certain anxiety behaviours in adolescence. Neonatal LPS 
administration resulted in increased anxiety in the elevated plus maze, as measured by 
reduced percent time in the open arms relative to neonatal saline treatment. Furthermore, 
males treated neonatally with LPS showed more vertical movements in the dark chamber 
than those treated with saline. However, no significant differences were observed between 
treatment groups in locomotor activity in the novel or familiar open field. Finally, no sex 
differences were observed in any of the various anxiety-related tests. 
 Males and females treated neonatally with LPS showed less percent time in the open 
arms of the elevated plus maze than animals treated with saline, although no other significant 
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differences between treatment groups were found in other anxiety-related behaviours. 
Nevertheless, the percent time in the open arms is a well-established index of anxiety, as it 
relies upon animals’ proclivity toward dark, enclosed spaces and an unconditioned fear of 
open spaces. Behaviour in this test reflects a natural conflict between preference for the 
safety of the closed arms and an innate tendency to explore a novel environment. 
Furthermore, anxiogenic drugs result in reduced time spent in the open arms, whereas 
anxiolytic drugs increase the time spent in the open arms, thereby demonstrating the validity 
of this measure in assessing anxiety (Walf & Frye, 2007). The findings of the current study 
suggest that neonatal endotoxin exposure results in highly specific changes in adolescent 
anxiety behaviour, as demonstrated by the significant behavioural differences between 
neonatal treatment groups in percent time spent in the open arms. 
 Neonatal LPS treatment did not seem to significantly affect adolescent locomotor 
activity behaviour in the novel or familiar open field, as animals treated with LPS as neonates 
demonstrated similar activity relative to animals treated with saline. Moreover, all adolescent 
animals showed similar thigmotaxic behaviours, as both neonatal LPS and neonatal saline 
groups spent more time in the periphery than the center area on both test days. Finally, all of 
the animals demonstrated habituation to the open field, with reduced activity in the familiar 
environment relative to the novel environment. Similarly, adolescent animals demonstrated 
similar patterns of behaviour in the light-dark test. All animals spent more time in the dark 
chamber than the light chamber, but exhibited greater activity levels in the light chamber. 
No sex differences were observed for any of the tests of anxiety. This finding is 
unique as previous research suggests that female adolescents tend to exhibit less anxiety-
related behaviour than males in the elevated plus maze (Imhof, Coelho, Schmitt, Morato, & 
Carobrez, 1993), the open-field (Masur, Schutz, & Boerngen, 1980), and the light-dark tests 
(Tenk, 2007). This sexual dimorphism has been shown to continue into adulthood for some 
tests, such as the elevated plus maze (Johnston & File, 1991; Zimmerberg & Farley, 1993) 
and the light-dark test (Hughes, Desmond, & Fisher, 2004). The developmental period of 
adolescence is not commonly studied, and there is limited data on sex differences during this 
developmental period, indicating that further research is warranted. It is possible that the 
increased exploratory behaviour, characteristic of adolescence, results in similar behavioural 
responses in both sexes, despite some anxiety produced by the testing environments common 
to both sexes. 
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Anxiety-related behaviour may be modulated by developmental stage. The adolescent 
period is a transitional developmental stage between youth and adulthood, and the age range 
spans from shortly after weaning until as late as 60 days (Spear, 2000). The majority of 
research indicates that male and female adolescent rats exhibit less anxiety-related behaviour 
than adults. Such results have been found in the light-dark test (Schramm-Sapyta, Cha, 
Chaudhry, Wilson, Swartzwelder, & Kuhn, 2007), the elevated plus maze (Imhof, Coelho, 
Schmitt, Morato, & Carobrez, 1993; Meyza, Boguszewski, Niko, & Zagrodzka, 2011), the 
open field test (Masur, Schutz, & Boerngen, 1980), and hole board exploration (Meyza, 
Boguszewski, Niko, & Zagrodzka, 2011). Adolescents also tend to show more exploratory 
and risk-taking behaviour than adults, and this is observed across many mammalian species. 
Adolescent rodents are hyperactive and demonstrate greater exploration in a novel 
environment, exhibit higher levels of novelty seeking, and elevations in social interactions 
relative to their adult counterparts (Spear, 2000; Doremus, Varlinskaya, & Spear, 2004; 
Stansfield & Kirstein, 2006). Adolescent rats also show hyper-reactivity to stimuli, with 
greater startle response amplitude than adults. Such age-related changes may help 
adolescents to successfully negotiate the transition from dependence in childhood to 
independence in adulthood and provide the opportunity for acquisition of necessary survival 
skills (Spear, 2000; Meyza, Boguszewski, Niko, & Zagrodzka, 2011).  
These differences in behaviour during adolescence may explain why animals treated 
neonatally with LPS showed similar behaviours in some tests of anxiety to animals treated 
with saline. Sickness behaviours are considered to be the expression of an organized strategy 
critical to survival (Dantzer, 2001). Infection results in altered behaviour such as lethargy and 
reductions in food and water intake in order to overcome the disease. As such, sickness is 
considered a motivational state that enables individuals to reorganize their behaviour 
depending on the circumstances. For instance, fear-motivated behaviour takes precedence 
over sickness behaviours in a dangerous situation order to satisfy more urgent needs. This 
phenomenon has been demonstrated in studies that show that the depressing effects of IL-1β 
are more prominent when animals are in the safe surroundings of home cages compared to a 
novel environment (Dantzer, 2001). It is therefore possible that neonatal LPS treatment is not 
sufficient to induce increased anxiety in the open field and light-dark tests because the 
motivation to experience new and intense stimuli through increased exploratory and risk-
taking behaviour in adolescence take precedence (Meyza, Boguszewski, Niko, & Zagrodzka, 
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2011). As such, in the novel environments (unique from the home cages), adolescent animals 
show some anxiety-related behaviours, such as thigmotaxis and greater duration in the dark 
chamber, but also show increased exploration common to this developmental period 
regardless of neonatal treatment.  
Most studies to date use one of two treatment protocols to explore the effects of early 
immune system activation on later responses. The dual-exposure-to-endotoxin (DEE) model 
involves two administrations of LPS on postnatal days 3 and 5 (e.g. Shanks et al., 1994; 
Breivik et al., 2002; Walker et al., 2004a). Results of studies that utilize this protocol have 
shown that DEE model alters anxiety-related behaviour in adulthood such that anxiety is 
increased on some tests but decreased on others (Breivik et al., 2002; Walker et al., 2004b). 
The second neonatal LPS regime involves a single injection of LPS on postnatal day 14 
(Boisse et al., 2004; Spencer et al., 2005; Spencer et al., 2006a). This protocol seems to result 
in adult immune system tolerance, such as decreased cytokine release (Ellis et al., 2005) and 
attenuation of the febrile response (Boisse et al., 2004; Ellis et al., 2005; Spencer et al., 
2006). However, the results of other studies have shown more variable results, with LPS 
administration on postnatal day 14 resulting in reduced exploration of novel objects, but 
having no effect on anxiety-related behaviours in the elevated plus maze, forced swim test, or 
open-field (Spencer et al., 2005).  
These two protocols have investigated adult anxiety behaviours following neonatal 
endotoxin exposure. Thus, the current experiment advances this area of research and further 
develops these protocols by providing a novel investigation of the effects of neonatal LPS 
treatment (DEE model) on adolescent anxiety behaviours. Given that adolescence is a 
transitional period associated with many changes and new experiences, this development 
stage may be considered extremely stressful, and many psychopathological disorders emerge 
during this period. However, results from previous studies have demonstrated that stress (e.g. 
novel environment and predator odor) during early adolescence results in decreased anxiety-
like behaviour and increased risk taking and novelty seeking behaviour during late 
adolescence in the open field, elevated plus maze, and novel object tests (Toledo-Rodriguez 
& Sandi, 2011). This suggests that seeking out and learning from novel stressors is necessary 
for growth towards independence in adulthood. Furthermore, adolescents tend to show 
greater extremes in mood, which may be adaptive, as heightened emotionality may increase 
animals’ vigilance to potential threats in novel environments (Meyza, Boguszewski, Niko, & 
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Zagrodzka, 2011). Thus, the results of the present study are consistent with previous research 
and add novel findings, which suggest that neonatal experiences may alter certain adolescent 
anxiety-related behavioural responses to stressors, but not others.  
Variability among individual animals and differences in behaviour can be interpreted 
as reflecting differences in personality. The combination of genetic factors, along with the 
contribution of early physical and social environment, help to shape individual differences in 
personality and behaviour (Trillmich & Hudson, 2011). Moreover, psychopathological 
anxiety is considered to a product of this interaction between early environmental factors and 
genetic susceptibility that produce structural and functional changes in the brain that underlie 
this disorder (Gross & Hen, 2004). Such precursors of personality may begin prenatally, 
including nutritional and endocrine conditions in utero. Postnatally, such influences may 
include litter size and body mass, maternal care, and other environmental conditions or 
potential stressors. It is assumed that differences in behavioural temperament develop in 
order to enhance an individual’s ability to survive challenges presented by the early 
environment. Such differences develop through interactions of endocrine, neuronal and 
immunological process, and are maintained throughout development, leading to differences 
in adult behaviour and reactivity to stressors (Trillmich & Hudson, 2011). For instance, 
results of previous research have shown that heavier rat pups (i.e. larger body mass) are 
bolder and more explorative in later stages of development (Rödel & Meyer, 2011). 
Furthermore, large and small litter sizes resulted in animals with greater anxiety, relative to 
medium sized litters, due to the adoption of behavioural styles depending on the size of the 
litter. This suggests that early environmental factors such as body mass and litter size 
influence changes in behavioural responses and the development of personalities.  
Thus, understanding individual differences in behavioural temperament or personality 
may help to explain variability that remains in experimental research despite standardization 
efforts (Lewejohann, Zipser, & Sachser, 2011). Behavioural consistency across time and 
context can be observed through correlations between behavioural variables and may reveal 
distinct animal personality traits that are maintained throughout the life cycle (Groothuis & 
Trillmich, 2011). The results of the correlation analyses in the current study provide evidence 
for individual differences in the animals tested, and suggest that the development of 
behavioural temperament from early environmental influences may play a role in the 
behavioural responses to stressors in adolescence.  
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Results suggest that the elevated plus maze, open-field and light-dark tests are 
reliable measures of anxiety due to the significant relationships between behavioural 
measures within a test. The elevated plus maze shows strong relationships between classic 
anxiety variables such as duration in the closed arms, as well as number of entries and 
percent time in open arms. Furthermore, certain risk assessment behaviours (body stretch 
attends) were also correlated with the traditional measures. Similarly, the locomotor variables 
in the novel and familiar open field were significantly correlated with one another, as well as 
variables assessing thigmotaxis behaviours. There were also significant correlations between 
variables within the light and dark chamber respectively, as well as significant relationships 
between variables across the two chambers. Such results suggest that these tests are reliable 
indices of anxiety. However, there was variability in the relationships, as not every treatment 
group demonstrated significant correlations for every test. Such variance emphasizes that 
individual differences in behavioural temperament play a role in how anxiety-related 
behaviours are expressed and observed.  
Many significant correlations were observed between tests, suggesting that such 
measures are assessing anxiety. However, not all tests demonstrated considerable correlation. 
These findings suggest that the various tests might measure different constructs of anxiety, 
which may be influenced by individual differences in the animals. This highlights the 
importance of using multiple tests to assess behaviour, because while measures of multiple 
ethological tests may be inter-related, they may also assess independent constructs. Results 
from previous research have found that variables from the elevated plus maze and open field 
do not produce common anxiety-related factor in rats (Ramos, 2008). Results of the current 
study are consistent with this, as only a few significant correlations were found between 
measures of the elevated plus maze and the open field. Similarly, very few significant 
relationships between the elevated plus maze and the light-dark test emerged. The inter-test 
variations within the study indicate construct differences between tests and more detailed 
analyses, such as factor analysis, should be conducted to better understand the constructs 
being tested. Moreover, the variations in correlations between treatment groups suggest that 
individual differences in emotionality also play a role in the observed constructs of anxiety. 
This may explain why certain treatment groups show a greater number of significant 
correlations in measures of anxiety between tests than others. For instance, males treated 
neonatally with saline and females treated neonatally with LPS show a greater number of 
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significant correlations between measures in the light-dark test and the novel and familiar 
open field, as well as various thigmotaxis behaviours. However, all treatment groups show a 
relatively equal number of correlations when comparing the elevated plus maze with other 
tests. Such analyses provide a better understanding of how early environmental factors 
interact with genetic susceptibilities to influence the expression of various anxiety behaviours 
in later life. The results also emphasize that a battery of tests may provide more valuable 
information on various overlapping constructs of the same trait.   
The results of the current experiment show that neonatal LPS treatment has effects on 
certain anxiety behaviours, which may be observed in certain tests, but not in others. 
Furthermore, typical adolescent behaviours common to both males and females, such as 
exploration and risk-taking may take precedence over anxiety and alterations due to neonatal 
endotoxin exposure. Finally, individual differences in personality and behavioural 
temperament may affect the way in which anxiety-related behaviours are expressed. Future 
research is warranted in this area to better understand these influences. Taken together, these 
results have potential clinical significance given that neonatal exposure to infection is 
common, and identifies potential risk factors in infants exposed to early bacterial infection. 
Furthermore, this study has empirical significance, as adolescence is a time of numerous 
developmental changes that has not been studied in great detail to date.   
49 
 
2.6 References 
Adriani, W., Seta, D., Dess-Fulgheri, F., Farabollini, F., & Laviola, G. (2003). Altered 
profiles of spontaneous novelty seeking, implusive behaviour, and response to D-
amphetamine in rats perinatally exposed to bisphenol. An Environmental Health 
Perspective, 111, 392-401. 
Andrade, M., Tome, M., Santiago, E., Lucia-Santos, A., & de Andrade, T. (2003). 
Longitudinal study of daily variation of rats' behaviour in the elevated plus-maze. 
Physiology & Behaviour, 71(1), 125-133. 
Archer, J. (1975). Rodent sex differences in emotional and related behaviour. Behavioural 
Biology, 71, 451-479. 
Boisse, L., Mouihate, A., Ellis, S., & Pittman, Q. (2004). Long-term alterations in 
neuroimmune responses after neonatal exposure to lipopolysaccharide. Journal of 
Neuroscience, 23, 4928-4934. 
Bourin, M., & Hascoet, M. (2003). The mouse light/dark box test. European Journal of 
Pharmacology, 463, 55-65. 
Breivik, T., Stephan, M., Brabant, G. E., Straub, R. H., Pabst, R., & von Hörsten, S. (2002). 
Postnatal lipopolysaccharide-induced illness predisposes to periodontal disease in 
adulthood. Brain, Behaviour, and Immunity, 16, 421–438. 
Crawley, J., & Goodwin, F. (1980). Preliminary report of a simple animal behaviour model 
for the aniolytic effects of benzodiazepines. Pharmacology Biochemistry and 
Behaviour, 13, 167–170. 
Curtis, K., Davis, L., Johnson, A., Therrien, K., & Contreras, R. (2004). Sex differences in 
behavioural taste responses to and ingestion of sucrose and NaCl solution by rats. 
Physiology and Behaviour, 80, 657-664. 
Dantzer, R. (2001). Cytokine-induced sickness behaviour: Where do we stand? Brain 
Behaviour and Immunity, 15, 7-24. 
Dent, G., Smith, M., & Levine, S. (1999). The ontogeny of the neuroendocrineresponse to 
endotoxin. Developmental Brain Research, 117 (1), 21–29. 
Doremus, T., Varlinskaya, E., & Spear, L. (2004). In Dahl R. E., Spear L. P. (Eds.), Age-
related differences in elevated plus maze behaviour between adolescent and adult 
rats. New York, New York, US: New York Academy of Sciences. 
50 
 
Ellis, S., Mouihate, A., & Pittman, Q. (2005). Early life immune challenge alters innate 
immune responses to lipopolysaccharide: Implications for host defense as adults. 
FASEB Journal, 19, 1519-1521. 
Gaillard, R., & Spinedi, E. (1998). Sex and stress-steroids interactions and the immune 
system: Evidence for neuroendocrine-immunological sexual dimorphism. Domestic 
Animal Endocrinology, 15 (5), 345-352. 
Genn, R., Tucci, S., Thomas, A., Edwards, J., & File, S. (2003). Age-associated sex 
differences in response to food deprivation in two animal tests of anxiety. 
Neuroscience and Biobehavioural Reviews, 27, 155-161. 
Gray, J., & McNaughton, M. (2003). The neuropsychology of anxiety: An enquiry into the 
functions of the septo-hippocampal system (Second ed.). New York: Oxford 
Univeristy Press. 
Groothuis, T., & Trillmich, F. (2011). Unfolding personalities: The importance of studying 
ontogeny. Developmental Psychology, 52, 641-655. 
Gross, C., & Hen, R. (2004). The developmental origins of anxiety. Nature Reviews 
Neuroscience, 5, 545-552. 
Hodgson, D., Knott, B., & Walker, F. (2001). Neonatal endotoxin exposure influences HPA 
responsivity and impairs tumor immunity in Fischer 344 rats in adulthood. Pediatric 
Research, 50, 750–755. 
Hughes, R., Desmond, C., & Fisher, L. (2004). Room novelty, sex, scopolamine and their 
interactions as determinants of general activity and rearing, and light–dark 
preferences in rats. Behavioural Processes, 67, 173–181. 
Imhof, J., Coelho, Z., Schmitt, M., Morato, G., & Carobrez, A. (1993). Influence of gender 
and age on performance of rats in the elevated plus maze apparatus. Behavioural 
Brain Research, 56(2), 177-180. 
Johnston, A., & File, S. (1991). Sex differences in animal tests of anxiety. Physiology and 
Behaviour, 49, 245-250. 
Lacosta, S., Merali, Z., & Anisman, H. (1999). Behavioural and neurochemical consequences 
of lipopolysaccharide in mice: anxiogenic-like effects. Brain Research, 818, 291-303. 
Lewejohann, L., Zipser, B., & Sachser, N. (2011). "Personality" in laboratory mice used for 
biochemical research: A way of understanding variability? Developmental 
Psychology, 53, 624–630. 
51 
 
Masur, J., Schutz, M., & Boerngen, R. (1980). Gender differences in open-field behaviour as 
a function of age. Developmental Psychobiology, 13(2), 107-110. 
Meng, I., & Drugant, R. (1993). Sex differences in open-field behaviour in response to the β-
Carboline FG 7142 in rats. Physiology and Behaviour, 54, 701-705. 
Meyza, K., Boguszewski, P., Niko, E., & Zagrodzka, J. (2011). Age increases anxiety and 
reactivity of the fear/anxiety circuit in Lewis rats. Behavioural Brain Research, 225, 
192–200. 
Misslin, R., & Cigrang, M. (1986). Does neophobia necessarily imply fear or anxiety. 
Behavioural Processes, 12, 45-50. 
Ossenkopp, K.-P., & Kavaliers, M. (1996). Measuring spontaneous locomotor activity in 
small mammals. In K.-P. Ossenkopp, M. Kavaliers, & P. (. Samberg, Measuring 
movemetn and locomotor: From invertebrates to humans (pp. 33-59). Georegtown, 
TX: Landes Company. 
Prut, L., & Belzung, C. (2003). The open field as a paradigm to measure the effects of drugs 
on anxiety-lik behaiours: A review. European Journal of Pharmacology, 463, 3-33. 
Rödel, H., & Meyer, S. (2011). Early development influences ontogeny of personality types 
in young laboratory rats. Developmental Psychology, 53, 601–613. 
Ramos, A. (2008). Animal models of anxiety: Do I need multiple tests?. Trends in 
Pharmacological Sciences, 29 (10), 493-498. 
Rico, J., Ferraz, D., Ramalho-Pinto, F., & Morato, S. (2010). Neonatal exposure to LPS leads 
to heightened exploratory activity in adolescent rats. Behavioural Brain Research, 
215, 102–109. 
Rodgers, R., Cao, B.-J., Dalvi, A., & Holmes, A. (1997). Animal models of anxiety: An 
ethological perspective. Brazilian Journal of Medical and Biological Research, 30 (3), 
289-304. 
Romana, E., & Arborelius, L. (2009). Male but not female Wistar rats show increased 
anxiety-like behaviour in response to bright light in the defensive withdrawal test. 
Behavioural Brain Research, 202, 303–307. 
Romanovskya, A., & Székely, M. (1998). Fever and hypothermia: two adaptive 
thermoregulatory responses to systemic inflammation. Medical Hypotheses, 50(3), 
219–226. 
52 
 
Schramm-Sapyta, N., Cha, Y., Chaudhry, S., Wilson, W., Swartzwelder, H., & Kuhn, C. 
(2007). Differential anxogenic, aversive and locomotor effects of THC in adolescent 
and adult rats. Psychopharmacology, 191, 867-877. 
Shanks, N., & Meaney, M. (1994). Hypothalamic-pituitary-adrenal activation rollowing 
endotoxin administration in the developing rat: A CRH-mediated effect. Journal of 
Neuroendocrinology, 6, 375–383. 
Shanks, N., Larocque, S., & Meaney, M. (1995). Neonatal endotoxin exposure alters the 
development of the hypothalamic-pituitary-adrenal axis: Early illness and later 
responsivity to stress. The Journal of Neuroscience, 15 (1), 376-384. 
Shanks, N., McCormick, C., & Meaney, M. (1994). Sex differences in hypothalamic-
pituitary-adrenalresponding to endotoxinchallenge in the neonate: Reversal by 
gonadectomy. Developmental Brain Research, 79, 260–266. 
Shanks, N., Windle, R., Perks, P., Harbuz, M., Jessop, D., Ingram, C., et al. (2000). Early-life 
exposure to endotoxin alters hypothalamic-pituitary-adrenal function and 
predisposition to inflammation. Proceedings of the National Academy of Sciences of 
the United States of America, 97 (10), 5645-5650. 
Spear, L. (2000). The adolescent brain and age-related behavioural manifestations. 
Neuroscience and Biobehavioural Reviews, 24, 417-463. 
Spencer, S. J., Boisse, L., Mouihate, A., & Pittman, Q. J. (2006a). Long term alterations in 
neuroimmune responses of female rats after neonatal exposure to lipopolysaccharide. 
Brain Behaviour and Immunity, 20, 231-238. 
Spencer, S., Heida, J., & Pittman, Q. (2005). Early life immune challenge - effects on 
behavioural indices of adult rat fear and anxiety. Behavioural Brain Research, 164, 
231-238. 
Spencer, S., Martin, S., Mouihate, A., & Pittman, Q. (2006). Early-life immune challenge: 
Defining a critical window for effects on adult responses to immune challenge. 
Neuropsychopharmacology, 31, 1910-1918. 
Stansfield, K., & Kirstein, C. (2006). Effects of novelty on behaviour in the adolescent and 
adult rat. Developmental Psychobiology, 48(1), 10-15. 
Tenk, C. M. (2007). Adult behavioural outcomes of neonatal immune system activation with 
lipopolysaccharide. University of Western Ontario, Psychology. London: 
Unpublished doctoral dissertation. 
53 
 
Tenk, C., Kavaliers, M., & Ossenkopp, K.-P. (2008). Sexually dimorphic effects of neonatal 
immune system activation with lipopolysaccharide on the behavioural response to a 
homotypic adult immune challenge. International Journal of Developmental 
Neuroscience, 26, 331-338. 
Toledo-Rodriguez, M., & Sandi, C. (2011). Stress during adolescence increases novelty 
seeking and risk-taking behaviour in male and female rats. Frontiers in Behavioural 
Neuroscience, 5, 1-10. 
Treit, D., & Fundytus, M. (1988). Thigmotaxis as a test for anxiolytic activity in rats. 
Pharmacology, Biochemistry and Behaviour, 31, 959-962. 
Trillmich, F., & Hudson, R. (2011). The emergence of personality in animals: The need for a 
developmental approach. Developmental Psychology, 53, 505-509. 
Walf, A., & Frye, C. (2007). The use of the elevated plus maze as an assay of anxiety-related 
behaviour in rodents. Nature Protocols, 2, 322-238. 
Walker, F. R., Brogana, A., Roger, S., & Hodgson, D. M. (2004a). A profile of the 
immediate endocrine, metabolic and behavioural responses following a dual exposure 
to endotoxin in early life. Physiology and Behaviour, 83, 495-504. 
Walker, F. R., Hodyl, N. A., Krivanek, K. M., & Hodgson, D. M. (2006). Early life host–
bacteria relations and development: Long-term individual differences in 
neuroimmune function following neonatal endotoxin challenge. Physiology & 
Behaviour, 87, 126-134. 
Walker, F., March, J., & Hodgson, D. (2004b). Endotoxin exposure in early life alters the 
development of anxiety-like behaviour in the Fischer 344 rat. Behavioural Brain 
Research, 154, 63-69. 
Walsh, R. N., & Cummins, R. A. (1976). The open-field test: a critical review. Psychological 
Bulletin, 83, 63-69. 
Zimmerberg, B., & Farley, M. (1993). Sex differences in anxiety behaviour in rats: Role of 
gonadal hormones. Physiology and Behaviour, 54, 1119-1124. 
 
54 
 
CHAPTER 3 
Effects of Neonatal Immune System Activation with Lipopolysaccharide on Voluntary 
and Non-Voluntary Adult Anxiety Behaviours 
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3.1 Introduction 
Immune system activation in early life can affect disease susceptibility and have long 
lasting neurological and psychological effects during later developmental periods. The 
endotoxin lipopolysaccharide (LPS) is the active component of the cell wall of Gram-
negative bacteria and elicits a response mimicking responses to bacterial infection. 
Administration of LPS stimulates the immune and endocrine systems and induces the 
expression of proinflammatory cytokines responsible for the inflammatory response 
(Dantzer, 2001). The variety of adaptive physiological and behavioural symptoms produced 
is known as the acute phase sickness response.  
Sickness behaviour is considered to be the expression of an organized and adaptive 
strategy to combat invading pathogens and increase the likelihood of survival (Dantzer, 
2001). For instance, illness-induced inactivity allows the animal to avoid predation in a 
weakened condition, as well as conserve energy and body heat, thereby facilitating the 
production and maintenance of fever. Fever increases body temperature thus impairing 
bacterial and viral proliferation and survival, and enhances existing immune defence 
mechanisms (Galic, Spencer, Mouihate, & Pittman, 2009). When animals are prevented from 
developing fever, they have higher pathogen loads and are more likely to die from the 
infection (Hart, 1988).  
Results from previous research have provided evidence for a sex difference in 
immunity, with females showing enhanced functioning relative to males across the life span 
(Shanks, McCormick, & Meaney, 1994; Gaillard & Spinedi, 1998). Research has also 
demonstrated that immune system activation in the first week of life results in similar sex 
differentiated acute sickness response (Walker, Brogana, Roger, & Hodgson, 2004a; Dent, 
Smith, & Levine, 1999). Early acute LPS exposure results in long-term changes in 
behavioural and physiological processes, such as increased disease severity in adulthood 
following an immune challenge, elevated IL–6 levels, and increased susceptibility to 
periodontal disease in adulthood (Breivik, Stephan, Brabant, Straub, Pabst, & von Hörsten, 
2002). Furthermore, LPS administration on postnatal days 1, 3, 5, and 7 has been shown to 
result in reduced natural killer cell activity and decreased resistance to tumor colonization in 
adult male rats (Hodgson, Knott, & Walker, 2001). However, the effects of neonatal LPS 
treatment may be more complex. For instance, the results of some studies have shown that 
LPS administration on postnatal days 3 and 5 results in the reduction of inflammation and 
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development of arthritis in adulthood (Shanks, et al., 2000). Additionally, as observed in 
previous studies, early immune system activation also attenuates the febrile response 
following adult endotoxin challenge (Walker, Hodyl, Krivanek, & Hodgson, 2006).  
In contrast, LPS administration during later neonatal development appears to result in 
immune system tolerance. LPS exposure on postnatal day 14 has been shown to lead to 
decreased cytokine release (Ellis, Mouihate, & Pittman, 2005), as well as reduced fever 
response in adulthood following an LPS challenge (Boisse, Mouihate, Ellis, & Pittman, 2004; 
Ellis, Mouihate, & Pittman, 2005). Both male and female rats show attenuated hyperthermia 
in response to an LPS challenge in adulthood, although this response in females occurs 
without the accompanying upregulation of fever-mediating enzymes observed in males 
(Spencer, Boisse, Mouihate, & Pittman, 2006a). Furthermore, a sex difference is observed in 
how such neonatal LPS treatment affects adult ability to combat a more severe immune 
challenge in adulthood. Adult males treated neonatally with LPS show reduced hypothermia 
and enhanced hyperthermia following both a low and high dose of LPS in adulthood. In 
contrast, neontally LPS-treated females show a similar response with a low, but not high dose 
of LPS (Spencer, Field, & Pittman, 2010).  
Beyond altered immune functioning, neonatal LPS administration also exerts many 
long-term changes on anxiety-related behaviours in adulthood, such that anxiety behaviour is 
increased on some tests but decreased on others (Tenk, 2007). LPS exposure in early 
development has been shown to lead to enhanced responsivity to restraint stress (Shanks, 
Larocque, & Meaney, 1995), increased sensitivity to noise (Shanks, et al., 2000) and pain 
(Boisse, Spencer, Mouihate, Vergnolle, & Pittman, 2005) in adulthood. Additionally, acute 
neonatal LPS has been shown to increase adult anxiety behaviour in the light-dark test 
(Lacosta, Merali, & Anisman, 1999) and the elevated plus maze (Breivik et al., 2002; 
Walker, March, & Hodgson, 2004b). Other studies report no effect of neonatal LPS treatment 
on performance in the elevated plus maze, but reductions in exploration of novel objects in 
an open-field (Spencer, Heida, & Pittman, 2005). Reserach has also shown that adult males 
treated neonatally with LPS show hypoactivity in a non-novel open field test in adulthood in 
response to an LPS challenge (Tenk, Kavaliers, & Ossenkopp, 2008), while other findings 
have shown that early LPS exposure does not result in increased anxiety in an open-field test 
(Breivik et al., 2002). Furthermore, studies have also shown that female rats neonatally 
exposed to LPS show hyperactivity in a novel open field (Nilsson, Jennische, Ho, Eriksson, 
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Bjorntorp, & Holmang, 2002). It is clear that while some studies demonstrate effects of 
neonatal LPS exposure in adulthood without re-activation of the immune system, other 
studies purport that re-activation with a “second hit” of LPS is necessary to produce such 
behavioural changes (Williamson, Sholar, Mistry, Smith, & Bilbo, 2011). Thus, these studies 
not only highlight the inconsistent effects of early immune system challenge, but also call 
into question the necessity of activating the immune system again in adulthood in order to 
observe these changes. 
A number of animal models used to assess anxiety-related behaviour in rodents have 
been discussed earlier (Chapter 2). These include the elevated plus maze and/or light-dark 
test, in which an animal is exposed to stressors such as a novel situation, open space, and/or 
bright light (Walsh & Cummins, 1976; Crawley & Goodwin, 1980). However, additional 
anxiety-related behavioural measures were considered for this study. For instance, animals 
experience taste neophobia, particularly those that lack the ability to vomit, which causes 
them to consume only a small amount of a novel food or fluid until the food has been proven 
safe to ingest (Corey, 1978). Taste neophobia is an ethologically valid measured used to 
assess anxiety-related behaviours in rodents (Dulawa & Hen, 2005; Merali, Levac, & 
Anisman, 2003), demonstrated by its sensitivity to both anxiogenic (Shephard & Broadhurst, 
1982) and anxiolytic (Cooper, 1980; Shephard & Estall, 1984) compounds. 
LPS administration has been found to lead to reductions in voluntary locomotor 
activity. In addition, LPS has been shown to induce non-voluntary motor responses. The 
acoustic startle response is a defensive sensorimotor reflex in response to a sudden burst of 
auditory stimulation, which is hypothesized to have evolved as an adaptive response to 
predator attacks (Hebb, Zacharko, Gauthier, & Drolet, 2003; Lockey, Kavaliers, & 
Ossenkopp, 2009). The resulting reflex is a non-voluntary contraction of the skeletal muscles 
such that the subject will appear to jump (Hoffman & Ison, 1980). The prepulse inhibition 
(PPI) measure is a well-studied startle paradigm, which is used to operationally measure 
“sensorimotor gating”. PPI refers to a level of neural processing at which irrelevant sensory 
stimuli are disallowed access to sensory processing areas. Normal PPI performance requires 
adequate sensory detection and processing in order for the animal to allocate attentional 
resources to more salient stimuli (Swerdlow, Geyer, & Braff, 2001). In research studies, PPI 
refers to the relative decrease in the magnitude of the startle response when the startling 
stimulus is preceded by a non-startle inducing sensory input (Lockey, Kavaliers, & 
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Ossenkopp, 2009). Results have shown that LPS treatment in adult rats resulted in significant 
reductions in startle response magnitude, suggesting an ability to modulate sensorimotor 
reflexes, but had no effect on sensory processing (PPI) (Lockey, Kavaliers, & Ossenkopp, 
2009).  
There are inconsistent findings not only in the behavioural responses to neonatal 
immune system manipulations in adulthood, but also in the observed sex differences in such 
responses. Furthermore, there is a lack of consideration of the possible effects of early 
immune system challenge on non-voluntary sensorimotor responses in adulthood. As such, 
the current experiment examined the effects of neonatal LPS administration on male and 
female adult anxiety-related behaviours. This study examined anxiety behaviours in 
adulthood unaccompanied by additional manipulations, as well as following an additional 
immune system challenge with LPS. Observations in the elevated plus maze, light-dark test 
and taste neophobia test were used as behavioural indices of adult anxiety. Additionally, 
acoustic startle response and PPI were measured, in order to gain better understanding of the 
effects of neonatal LPS administration on non-voluntary motor activity. 
3.2 Methods 
3.2.1 Animals  
Following adolescent behavioural testing in experiment 1, animals were left 
undisturbed until adulthood. Animals remained pair-housed (same-sex, same-treatment 
littermates) in standard polypropylene cages (45 x 22 x 20 cm) in a temperature-controlled 
colony room (21 ± 1 oC), and maintained on a 12:12 light – dark cycle with the lights on at 
07:00 hours. Food (Prolab rat chow) and water were available ad libitum, unless otherwise 
specified. On postnatal day 74, animals were single-housed for the final testing procedures. 
Experimental manipulations were conducted during the light phase of the light – dark cycle 
and body weight was monitored during testing. All procedures were approved by the 
University of Western Ontario Animal Care Committee and were in accordance with the 
Canadian Council of Animal Care (CC guidelines).  
3.2.2 Drug Administration  
All animals received two challenge doses of LPS (200 µg/kg) in adulthood on P 71 
and P 72, derived from Escherichia Coli stereotype 0111:B4, L26030, Sigma Chemical, St. 
Louis, MO, USA) dissolved in 0.9% isotonic saline. Injections were given 1 ½ hours prior to 
testing.  
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3.2.3 Behavioural testing 
3.2.3.1 Startle apparatus. All acoustic startle response and prepulse inhibition (PPI) 
testing was conducted in 3 separate startle chambers (SRLAB, San Diego Instruments, San 
Diego, CA). Each chamber consisted of a cylindrical, clear acrylic rat enclosure (10.2 cm 
outside diameter) mounted on an acrylic platform. The platform sat on a piezoelectric 
accelerometer, which transduced the force of animal movement. This was placed inside a 
ventilated, sound attenuating box containing a mounted fluorescent light and a speaker which 
emitted the background noise, prepulse and acoustic startle stimuli. Data were recorded for 
100 ms immediately following the onset of the acoustic startle stimulus. Testing occurred in 
adulthood on P 70 (no LPS challenge) and P 72 (LPS challenge). 
In a testing session, lasting approximately 22 min, a 5 min acclimation period with 
background noise (70 dB) was followed by a 17 min (67 trials) testing session in which the 
70 dB background noise was maintained. Eleven trial types were used in the testing session; 
startle-alone trials (consisting of a 115 dB burst of white noise stimulation lasting 40 ms in 
duration), six different prepulse inhibition trial types (prepulse-pulse, categorized by the 
intensity of the prepulse and the inter-stimulus interval (ISI) between the prepulse and startle 
pulse; prepulses 3, 6 or 12 dB louder than the 70 dB background noise (73, 76 and 82 dB, 
respectively), each consisting of a 20 ms burst of white noise presented with an onset either 
120 ms prior to the startle pulse (100 ms ISI) or 80 ms prior to the startle pulse (60 ms ISI), 
and four control trial types (no pulse, 73, 76, or 82 dB prepulse only – to ensure animals 
responded only to startle pulse). The first 10 trials were startle-alone trials, which served to 
reduce the amount of variability measured for the startle response; these trials were not used 
in later analysis. The middle 52 trials (presented in pseudo-random order) consisted of 10 
startle-only, 30 PPI trials (5 each of 6 different PPI trial types), and 12 control trials (3 each 
of no pulse, 73, 76, or 82 dB only). The session ended with 5 startle-alone trials. All of the 
trials were separated by an inter-trial interval (ITI) of 8–23 s in length (average ITI = 15 s).  
Percent PPI to a particular prepulse-ISI trial type was calculated as response to startle alone 
trials (in the middle 52 trials of a session) minus the response to prepulse-pulse trials (i.e. 73 
db prepulse-pulse trial with ISI 100 ms) all divided by the response to startle-alone trials 
times 100. 
3.2.3.2 Elevated plus maze and light-dark tests. Behavioural variables were 
collected in the elevated plus maze and light dark tests described in experiment 1 (Chapter 2). 
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3.2.3.3 Drinking apparatus. Drinking behaviour of adult animals was recorded using 
eight automated drinking boxes (8 Channel Lickometer, DiLog Instruments, Tallahassee, 
FL). Each Lickometer consisted of a clear Plexiglas chamber (31 x 31 x 41 cm) with a 
removable Plexiglas lid containing airholes. A graduated drinking tube was mounted in the 
center of each chamber, with the spout 8 cm above the floor. Contact with the spout by the 
animal’s tongue completed a very low voltage electric circuit. These electrical responses 
were analyzed using the Lickometer system software (Qlick) to provide a microstructural 
analysis of licking patterns. Testing in the Lickometer took place on P 76 – 81 where animals 
were allowed to drink freely for 30 min. Variables generated included total volume ingested 
during each session in mL (volume) measured by noting the initial and final volumes in the 
graduated tubes recorded to the nearest half millimeter, and total number of licks per session 
(number of licks). Additionally, microstructural analysis of drinking behaviour illustrated the 
frequency of licks at each drinking spout. Licking burst was defined as the number of licks 
that occurred before an inter-lick interval of 250 ms (burst number) and the number of licks 
in each burst was also calculated (burst size). Bursts separated by pauses of approximately 
twice the duration of an inter-lick interval (500 ms) are grouped into clusters. The number of 
clusters, each measured as a group of bursts that have been interrupted by transient pauses in 
drinking, were calculated (cluster number), as well as the number of bursts within a cluster 
(cluster size). 
3.2.4 Procedure 
As previously described, 4 male and 4 female pups from each litter were left alone 
following tests in adolescence until adulthood. Body weight was measured weekly 
throughout the testing process, as well as on each day of behavioural testing. Behavioural 
testing occurred during adulthood on postnatal days 70- 72 and 75-82.  
Rats were tested in the startle apparatus on P 70 for approximately 22 min. On P 71 
all animals were given a challenge i.p. injection of LPS and tested in the elevated plus maze 
and the light-dark apparatus. Additionally, a second LPS challenge was administered on P 72 
and all animals were again tested in the startle apparatus. All behavioural testing occurred 1 
½ hr following LPS injections.  
Taste neophobia and intake of a novel sucrose solution was assessed for animals from 
litters 5- 11 only (male-LPS n = 14; male-NaCl n = 14; female-LPS n = 14; female-NaCl n = 
13). Following the three test days, animals were single-housed in preparation for water 
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habituation necessary in the final testing period. On P 75 rats were adjusted to a water 
restriction schedule. Animals received 30 min daily access to water in their home cages at the 
end of testing each day. Four days of habituation to the drinking boxes began on P 76. 
Animals were given access to distilled water in the Lickometer for 30 min each morning. The 
final day of habituation (P 79) was designated as the baseline day. Following habituation, 
animals were given access to 0.3M sucrose solution for 30 min daily on two consecutive days 
(P 80 and P 81). The first exposure to the novel sucrose provided measures of taste 
neophobia, while the second produced an index of intake (Tenk, 2007).  See Figure 3.1 for a 
timeline of the behavioural procedure. 
3.2.5 Statistical analysis 
All analyses were performed with IBM SPSS Statistics 19 (formerly PASW Statistics 
18). Significance was set to α = .05. 
3.2.5.1 Changes in body weight. A univariate analysis of variance (ANOVA) was 
used to analyze changes in body weight, with the between subjects factors of Sex, Neonatal 
Treatment (2 levels: LPS or saline) and Litter (11 levels). When appropriate LSD post hoc 
test were used. 
3.2.5.2 Startle and prepulse inhibition. A univariate ANOVA was used to analyze 
average startle response, with the same between subjects variables mentioned above and 
Chamber used as a co-variate. Chamber refers to the 3 startle chambers used for testing; there 
were differences in the sensitivity of the chambers. Additionally, a repeated measures 
ANOVA was conducted to analyze differences in average startle response across the two test 
days, with the same between subjects factors mentioned previously, and a within subjects 
factor of Day (2 levels). Prepulse inhibition (PPI) data was analyzed using a repeated 
measures ANOVA for each ISI, with the same between subjects factors as average startle and 
the addition of prepulse level (73, 76, or 82 dB) as a within subjects factor. LSD test served 
as a post-hoc comparison when appropriate.  
3.2.5.3 Elevated plus maze (EPM). EPM data were analyzed using a multivariate 
analysis of variance (MANOVA), with the between subjects factors of Sex and Neonatal 
Treatment (2 levels: LPS, NaCl), and Litter (11 levels). Where appropriate, LSD test was 
used as a post-hoc comparison. 
3.2.5.4 Light-dark and lickometer tests. Behavioural data collected during the light-
dark and lickometer tests were analyzed using a mixed design (split-plot) analysis of variance  
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Fig. 3.1. Timeline for experiment 2. Neonatal drug treatment occurred on postnatal days 3 
and 5, followed by the testing period during adolescence (experiment 1), and behavioural 
testing during adulthood (postnatal days 70 – 81). Testing without adult immune system 
challenge occurred on postnatal day 70 in the startle apparatus and on postnatal days 76 – 81 
in the lickometer test. Testing adult immune system challenge occurred on postnatal days 71 
and 72. 
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(ANOVA) with between-subjects factors of Sex (2 levels: male and female) and Neonatal 
Treatment (2 levels: LPS or saline). Litter was also considered a between subjects factor with 
11 levels for the light-dark test and 6 levels for the lickometer test. The within subjects 
factors were Day and/or Time, which varied depending on the behavioural test being 
analyzed. For the light-dark tests, only a within subjects factor of Time was considered (6 
levels of 5- min time bins). For the lickometer tests, the within subjects factor of Day (3 
levels) was measured. Post-hoc comparisons of significant main effects and interactions were 
performed using LSD test when appropriate.  
3.3 Results 
3.3.1 Changes in Body Weight 
All animals demonstrated a reduction in body weight 24 hours following the initial 
injection of LPS on postnatal day 71 (see Figure 3.2). However, no significant differences 
were observed between treatment groups, as statistical analysis did not yield main effects of 
Sex (F(1, 43) =.171, p =.682) or Neonatal Treatment (F(1, 43) = .193, p = .662), or a 
significant interaction (F(1, 43) = .995, p = .334). Furthermore, as body weight was not 
collected after the second dose of LPS on postnatal 72, evidence of LPS tolerance could not 
be assessed.  
3.3.2 Elevated Plus Maze 
Due to the presence of outliers, five animals were excluded from the analyses of the 
various behavioural measures (2 male-NaCl, 1 male-LPS, 1 female-NaCl, 1 female-LPS 
animals excluded). Analysis revealed no differences between Neonatal Treatment groups in 
traditional anxiety behaviours in adulthood, despite receiving a challenge dose of LPS. 
However, analysis of the data yielded a significant main effect of Sex for the number of 
entries into the open arms, F(1, 38) = 5.51, p = .024, and the percentage of time spent in the 
open arms, F(1, 38) = 8.74, p = .005. Males showed reduced entries and percent time in the 
open arms as compared to females (Figure 3.3 A and B). No effects of Sex or Drug were 
found in the various risk assessment behaviours, inclusive of head and body stretch attends, 
head dips, and double backs. The MANOVA did not yield any Sex x Neonatal Treatment 
Interactions for any of the measures of anxiety in adulthood. For a summary of significance 
data see Appendix E. 
A significant main effect of Litter was found for several of the EPM variables  
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Fig. 3.2 Twenty-four hour group mean (± S.E.M) change in body weight following i.p. 
challenge injection of lipopolysaccharide (LPS; 200 µg/kg) in adulthood. All treatment 
groups show similar reductions in body weight (male-SAL: n = 23, male-LPS: n = 23, 
female-SAL: n = 19, female-LPS: n = 21). 
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Fig. 3.3 Group mean (± S.E.M.) anxiety-related behaviours in the elevated plus maze in 
adulthood (P71). (A) number of entries into the open arms (B)  percent time in open arms of 
the elevated plus maze (time spent in open arms/time spent in open arms + time spent in 
closed arms x 100). * p < .05 indicates a significant overall sex effect, females showed 
greater number of entries and percent time in the open arms as compared to males (male-
SAL: n = 21, male-LPS: n = 22, female-SAL: n = 18, female-LPS: n = 20). 
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including the number of open entries (F(10, 38) = 2.15, p = .001, the number of closed arm 
entries (F(10, 38) = 3.80, p = .007), the duration of time in the closed arms (F(10, 38) = 2.98, 
p = .007), the number of head dips (F(10, 38) = 2.80, p = .011), and duration of body stretch 
attends (F(10, 38) = 4.23, p = .001).  
3.3.3 Light-Dark Test 
Due to technical difficulties in obtaining data, two animals were excluded from this 
analysis (1 male-NaCl animal and 1 female-LPS animal excluded). A representative measure 
of horizontal activity (total distance, cm/min; duration, s) and vertical activity (total number 
of vertical movements, cm/min; total vertical movement time, cm/min) in both chambers is 
depicted in Figure 3.4A-D and a summary of significance data is represented in Appendix F.  
Statistical analysis indicated that all of the groups of animals spent significantly more 
time in the dark chamber during adulthood, F(1, 41) = 147.5,6 p < .001, although no 
differences between sexes and neonatal treatment groups were observed. All animals 
travelled more in the light chamber, F(1, 42) = 87.90, p < .001, and analysis of these data 
revealed a significant Sex x Neonatal Treatment interaction in the light chamber, F(1, 41) = 
4.41, p = .042. Males treated with NaCl travelled significantly more in the light chamber than 
males treated with LPS (p = .022). Additionally, females treated with LPS travelled 
significantly more in the light chamber than males treated with LPS (p = .010). 
Animals showed a greater amount of vertical activity in the light chamber, as 
compared to the dark chamber. All animals demonstrated a greater number of vertical 
movements, F(1, 42) = 207.01, p < .001, and greater duration of vertical movements, F(1, 
42) = 98.21, p < .001, in the light chamber. A main effect of Litter was observed for the total 
distance travelled (F(10, 41) = 2.68, p = .013) and duration of vertical movements (F(10, 41) 
= 2.12, p = .045) in the light chamber, as well as duration of vertical movements in the dark 
chamber, F(10, 41) = 4.34, p < .001. 
Finally, all animals entered the light chamber more often than the dark chamber, F(1, 
41) = 9.61, p = .004. Analysis revealed a main effect of time for number of entries in the light 
chamber (F(3, 131) = 101.48, p  < .001) and dark chamber (F(3, 102) = 68.34, p < .001), as 
well as for duration in the light (F(3, 127) = 12.96, p < .001) and dark chamber (F(3, 127) = 
13.00, p < .001). Thus, all animals demonstrated habituation to the environment, as the 
number of entries into the chambers decreased over the 30 min period. In addition, a main   
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Fig. 3.4. Group mean (± S.E.M.) activity behaviours in the light-dark test during adulthood 
(P71). (A) corrected total distance (cm travelled per min) in light and dark chambers (B) total 
duration (s) spent in light and dark chambers (C) corrected number of vertical movements 
(cm per min) in light and dark chambers (D) corrected vertical time (cm per min) in light and 
dark chambers. Horizontal lines represent the point at which equal time would be expected to 
be spent in each chamber. *p < .05 indicates significant Neonatal Drug x Sex interaction, 
where male-NaCl animals travelled more than male-LPS animals in the light chamber. + p < 
.05 female-LPS travelled more in the light chamber than male-LPS. ‘a’ indicates a significant 
main effect of chamber (p < .05) with all treatment groups spending more time in the dark 
chamber. ‘b’ indicates a significant main effect of chamber (p < .05) with all treatment 
groups travelling more, having greater number of vertical movements and greater vertical 
time in the light chamber (male-SAL: n = 22, male-LPS: n = 23, female-SAL: n = 19, 
female-LPS: n = 20). 
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effect of Litter was observed for number of entries into the light chamber, F(10, 41) = 4.18, p 
= .001 and dark chamber F(10, 41) = 6.17, p < .001. 
3.3.4 Startle and Prepulse Inhibition 
Analysis of average startle responses to startle-only trials yielded a significant main 
effect of Sex on both Day 70, F(1, 42) = 11.39, p = .002 and Day 72, F(1, 42) = 11.74, p = 
.001, where animals received a challenge injection of LPS 90 min before testing (Figure 3.5 
A and B). A main effect of Litter was also observed on Day 70, F(10, 42) = 3.23, p = .004  
and Day 72, F(10, 42) = 2.77, p = .010 (post hoc tests not reported). On both test days, males 
showed a larger startle response than females. Neonatal LPS treatment had no effect on 
average startle response. Furthermore, no main effect of Day was found for average startle 
between the two test days, F(1, 41) = .108, p = .744. There were no significant effects of Sex 
or Neonatal Treatment on percent prepulse inhibition, for each of the ISIs of 60 ms and 100 
ms on either test day (graphs not shown). A significant main effect of Litter was observed for 
the ISI of 60 ms on Day 70 (F(10, 42) = 2.21, p = .036) and Day 72 (F(10, 42) = 5.75, p < 
.001) (post hoc tests not reported). For a summary of significance data see Appendix G.  
3.3.5 Novel Sucrose Taste Neophobia 
Only seven litters were tested in the Lickometer, and due to technical difficulties in 
obtaining data, four animals were excluded from these analyses (2 male-NaCl, 1 female-
NaCl and 1 female-LPS animals excluded). Data analysis of taste neophobia examined 
changes in intake and licking patterns between baseline day and the first exposure to the 
sucrose solution. Each variable was computed as a difference between the values of the 
measure collected on the two days. Measures of overall consumption for each group are 
depicted in Figure 3.6 A and B. Neonatal LPS treatment had no significant effect on the 
volume consumed or the Number of Licks as evidenced by the lack of significant interactions 
or main effects on these measures. Statistical analysis of the microstructural variables (Size 
of Burst, Number of Bursts, Size of Cluster, and Number of Clusters) revealed no significant 
effects of Sex or Neonatal Treatment on drinking behaviour. A summary of significance data 
is depicted in Appendix H.  
3.3.6 Familiar Sucrose Intake 
Variable totals collected during the second exposure to sucrose were used as the 
measures of familiar sucrose intake. Consumption measures on this day for each group are 
depicted in Figure 3.6 A and B. A main effect of Sex was observed for volume consumption, 
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Fig. 3.5. Group mean (± S.E.M) amplitude of the acoustic startle response on Startle-Only 
trials (A) without adult LPS challenge (P70) and (B) 90 min following adult immune LPS 
challenge (P72). *p < .05 indicates significant main effect of sex, with males showing greater 
startle response than females (male-SAL: n = 23, male-LPS: n = 23, female-SAL: n = 19, 
female-LPS: n = 21).  
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Fig. 3.6. Measures of overall consumption displayed both as difference between baseline and 
initial exposure to sucrose (top), as well as totals consumed across days (bottom). (A) Group 
mean (± S.E.M) volume consumed (B) group mean (± S.E.M) number of licks. *p < .05 
indicates main effect of sex, as males consumed more fluid across days compared to females. 
+p < .05 indicates main effect of neonatal drug treatment, with saline-animals showing 
greater volume intake on baseline day than LPS-animals (male-SAL: n = 11, male-LPS: n = 
14, female-SAL: n = 14, female-LPS: n = 12).  
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F(1, 23) = 65.12, p < .001, as males drank significantly more fluid across all days compared 
to females. Finally, a main effect of Day was found, F(2, 46) = 35.10, p < .001), where 
consumption in all treatment groups increased from baseline to the final test day. The 
analysis did not yield any significant interactions. Statistical analysis revealed no significant 
effects of Sex of Neonatal Treatment for the Number of Licks or any of the microstructural 
variables. For a summary of significance data see in Appendix I. A significant main effect of 
Litter was found for volume, F(6, 23) = 16.36, p < .001 and the Number of Licks, F(6, 23) = 
6.10, p < .001 (post hoc tests not reported). 
3.4 Discussion 
 The current study examined the effects of neonatal LPS exposure on voluntary and 
non-voluntary behavioural responses in adults with and without an accompanying immune 
challenge. Furthermore, potential sex differences in these effects were explored. The findings 
of this study suggest that LPS treatment on postnatal days 3 and 5 may have specific long-
lasting effects on general anxiety behaviours in adulthood, as adult immune challenge did not 
significantly affect behaviours in the elevated plus maze for any of the treatment groups, but 
did result in differences in light dark test. Furthermore, adult anxiety-related behaviours in 
the elevated plus maze and light-dark tests were influenced by sex. Neonatal LPS exposure 
did not significantly affect non-voluntary startle reflex regardless of whether or not animals 
received an immune challenge in adulthood. Finally, neonatal LPS treatment did not have an 
effect on taste neophobia, but sex-specific differences in drinking behaviour were observed.  
Adult animals with and without neonatal LPS exposure showed similar patterns of 
heightened anxiety and risk assessment behaviours in the elevated plus maze. Acute LPS has 
been shown to increase anxiety-related behaviour in the elevated plus maze in adult rats 
(Nava, et al., 1997; Nava & Carta, 2001) and the light-dark test in adult mice (Lacosta, 
Merali, & Anisman, 1999). Thus, the effects of the adult immune challenge on anxiety 
behaviours in adulthood are consistent with results from previous research. However, 
neonatal LPS exposure did not significantly affect adult anxiety behaviours in the elevated 
plus maze in response to the adult immune challenge, as the animals treated neonatally with 
LPS showed similar behaviour patterns as the animals treated with saline. 
LPS challenge in adulthood similarly increased anxiety-related behaviours in the 
light-dark test in animals treated with and without neonatal LPS, with a greater duration of 
time spent in the dark chamber, and more escape-related behaviours in the light chamber. 
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However, neonatal LPS had a significant effect on distance travelled, as males treated 
neonatally with saline travelled more in the light chamber than males treated with LPS in 
response to an adult immune challenge. Results from prior research have been variable. 
Some studies report no influence of neonatal LPS exposure on anxiety-related behavioural 
(Walker, Knott, & Hodgson, 2008). Furthermore, results also show no effect of maternal 
endotoxin exposure (viral mimetic, Poly IC) on various adult behaviours, including those in 
the elevated zero maze, open-field, and light-dark test (Vorhees, et al., 2012). 
However, other studies present opposing findings that show neonatal LPS to result in 
increased adult anxiety in the elevated plus maze (Walker, March, & Hodgson, 2004b). 
Furthermore, repeated adult endotoxin treatment has been shown to cause an increase in 
sickness sympoms, corticosterone release, and anxiety behaviours (Schmidt, Janszen, 
Wouterlood, & Tilders, 1995; Hayley, Brebner, Lacosta, Merali, & Ainsman, 1999; Hayley, 
Lacosta, Merali, van Rooijen, & Ainsman, 2001). Although these findings suggest that 
neonatal LPS may intensify disease severity and increase the risk for anxiety following an 
immune challenge in adulthood, this was not observed in the current study in terms of 
anxiety-related behaviours in the elevated plus maze.  
All adult animals showed reductions in body weight 24 hours after the adult LPS 
injection, highlighting the physiological effects of acute LPS. However, no differences were 
found between those that received neonatal LPS or saline treatment. As all animals 
demonstrated similar physiological changes in terms of body weight loss, it may suggest that 
rather than increasing disease severity in adulthood, neonatal LPS may result in immune 
system tolerance. This has been found in previous studies demonstrating that treatment with 
neonatal LPS on postnatal days 3 and 5 results in attenuated fever following adult LPS 
adminstration (Walker, Hodyl, Krivanek, & Hodgson, 2006) and reduces the development of 
arthritis following an adult inflammatory challenge (Shanks, et al., 2000). 
 Neonatal LPS may not exert general long-lasting effects on anxiety in adulthood, as 
the treatment groups did not show differences in many of the anxiety-related behaviours. 
However, the finding that males treated neonatally with saline travelled significantly more in 
the light chamber than males treated with LPS following acute adult immune stimulation 
suggests that neonatal endotoxin exposure has highly specific effects on certain adult 
behavioural responses. The inconsistent findings from the various warrant more research on 
the various effects of neonatal endotoxin exposure on adult anxiety behaviours. 
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Sex differences in anxiety in response to adult immune challenge were found in the 
current study. Female rats from both the neonatal saline and LPS treatment groups similarly 
demonstrated more open arm entries and greater percent time in the open arms of the 
elevated plus maze compared to males. This finding is consistent with reports from previous 
studies suggesting that female rats have greater levels of basal activity in novel 
environments, indicative of less anxiety (Engeland, Kavaliers, & Ossenkopp, 2003a; 
Franklin, Engeland, Kavaliers, & Ossenkopp, 2003), and display less anxiety-related 
behaviour in the elevated plus maze (Zimmerberg & Farley, 1993). Furthermore, females 
treated neonatally with LPS travelled more in the light chamber than males treated with LPS. 
Results from previous research have demonstrated that females display less anxiety-related 
behaviour in the light dark test (Hughes, Desmond, & Fisher, 2004). Furthermore, while 
males treated neonatally with LPS were found to display significantly lower amounts of 
locomotor activity in the open field in response to adult LPS adminstration, neonatal LPS 
treatment did not induce similar hypoactivity in females (Tenk, 2007). This result is 
consistent with reports that males may be more susceptible to the effects of endotoxin than 
females in certain behavioural responses associated with a fear-inducing situation (Engeland, 
Kavaliers, & Ossenkopp, 2003; Franklin, Engeland, Kavaliers, & Ossenkopp, 2003). 
Previous reports have also suggested that sex differences in activity disappear once an 
environment is no longer novel (Engeland et al., 2003a; Franklin et al., 2003). However, this 
was not the case in the current study, suggesting that novelty is dependent on the duration of 
time between exposures. It is therefore possible that the length of time between the initial 
exposure to the elevated plus maze and light-dark tests (in adolescence) was enough to render 
the testing environment novel by the time animals reached adulthood. 
The mechanism underlying the observed sex difference in hypoactivity following an 
adult challenge remains unclear. It has been hypothesized that the immunosuppressive effects 
of testosterone may influence this response (Gaillard & Spinedi, 1998). As females have 
been shown to have enhanced immune functioning, it is possible that the adult LPS challenge 
resulted in greater immune system tolerance in females treated neonatally with LPS than in 
males. However, given that this sex difference was only found in one measure of locomotor 
activity, it is possible that it is another finding demonstrating greater levels of activity in 
females relative to males.  
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The present study found no significant effects of neonatal LPS administration on 
acoustic startle response and prepulse inhibition, either with or without endotoxin challenge 
in adulthood. All animals demonstrated similar patterns of average startle response when 
tested in the startle apparatus without adult challenge. This result is consistent with those 
from previous studies, which suggest that neonatal endotoxin exposure alone is not sufficient 
to produce abnormal startle responses (Walker, Knott, & Hodgson, 2008). However, results 
from previous studies have also shown deficits in adult startle response and PPI associated 
with neonatal endotoxin exposure (Tohmi, Tsuda, Watanabe, Kakita, & Nawa, 2004), as well 
as reductions in female, but not male, startle response associated with prenatal endotoxin 
exposure (Vorhees, et al., 2012). Therefore, effects of neonatal LPS treatment on startle 
response seem to be inconclusive.  
Results of the current study also show that neonatal LPS exposure did not 
significantly affect startle response following adult immune activation. Acute LPS treatment 
has been shown to significantly reduce startle response magnitude (Lockey, Kavaliers, & 
Ossenkopp, 2009). Furthermore, previous studies have suggested that neonatal LPS treatment 
results in exaggerated startle following exposure to stress (Walker, Knott, & Hodgson, 2008). 
Therefore, it was expected that the neonatal saline-treated animals would show reduced 
startle responses relative to the neonatal LPS-treated animals following an adult immune 
challenge. It should be noted that animals received an injection of LPS less than 24 hours 
prior to the second injection of LPS. Animals develop rapid physiological and behavioural 
tolerance to LPS immediately following the first administration (Zeisberger & Roth, 1998), 
and this may suggest that all animals showed similar startle patterns due to tolerance 
development. Furthermore, given that no differences were observed between startle 
responses on the first and second test days for any treatment groups, it is unlikely that 
behavioural tolerance to the startle apparatus was developed.  
Sexual dimorphism in average startle response was observed on both test days, with 
males demonstrating greater average startle than females. This result is consistent with 
results from some previous research, which found males to have greater acoustic startle 
response than females (Lehmann, Pryce, & Feldon, 1999). This is also consistent with 
findings indicating that males showed enhanced anxiety relative to females (Zimmerberg & 
Farley, 1993). However, no sex differences were observed in prepulse inhibition, which is 
inconsistent with previous studies that found males to have enhanced PPI relative to females 
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(Lehmann, Pryce, & Feldon, 1999). This effect may vary depending on the strain of animal 
tested. For instance, previous research has shown that Sprague-Dawley rats are more 
sensitive than Long Evans rats to the PPI disruptive effects of dopamine agonists (Qu, Saint 
Marie, Breier, Ko, Stouffer, & Parsons, 2009). Furthermore, results of prior studies have 
shown that restraint stress decreases PPI in female Long Evans rats, but does not affect males 
or other rat strains (Faraday, 2002). Finally, research has also shown Long-Evans rats to have 
high mean startle amplitude relative to many other strains of rat (Glowa & Hansen, 1994). As 
such, results seem to be inconsistent across studies, and the observed effects of acoustic 
startle response and PPI may be influenced by rat strain.  
Neonatal LPS administration did not appear to alter drinking behaviour during the 
taste neophobia task, as all animals showed similar patterns of drinking in response to the 
novel sucrose solution. This suggests that early endotoxin exposure may not influence novel 
taste-related anxiety in adulthood. Furthermore, neonatal LPS treatment did not affect 
drinking behaviours in adulthood in response to familiar sucrose solution. These findings are 
similar to results from some previous research, which found no effect of neonatal LPS on 
initial or familiar consumption behaviours (Tenk, 2007). However, other studies have 
demonstrated that prenatal psychological stress (e.g. novel environment) leads to increased 
taste neophobia in adulthood (Pfister, Golus, & McGee, 1981). These inconsistent findings 
suggest that the developmental period during which animals are exposed to pathogens may 
have differing effects on anxiety behaviours in adulthood. Results from previous studies have 
also demonstrated differences in licking patterns, and suggest that neonatal LPS may 
influence situational anxiety, such that animals treated with LPS neonatally show fewer risk 
assessment behaviours in licking patterns than those treated with saline (Tenk, 2007). The 
current study did not replicate these results, and further research is required to determine 
whether neonatal LPS has significant effects on anxiety-related drinking behaviours. 
All animals showed consistent drinking patterns, whereby volume consumed 
increased across test days. Thus, all animals drank more of the sucrose solution on the first 
day compared to water consumption on baseline day, and drank significantly more sucrose 
on the second test day compared to the initial exposure. This suggests that while animals 
liked the palatable sucrose during the initial exposure, they all showed expected taste 
neophobia, which disappeared by the second sucrose exposure (Corey, 1978).  
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Depressive-like behaviours are associated with increased secretion of cytokines, 
indicative of a relationship between immune system activation and depression (Connor & 
Leonard, 1998). While non-treated rats show a preference for the palatable fluids such as 
sucrose, acute LPS administration results in anhedonia (inability to experience pleasure), 
demonstrated by reductions in preference for and consumption of saccharine (Yirmiya, 
1996). Furthermore, such effects are reversed with chronic administration of antidepressants 
(Yirmiya, 1996). However, early life manipulations such as handling, separation, and 
deprivation have been shown to have varying effects on depressive behaviours. While there 
are some reports of decreased sucrose preference following early life stressors, other findings 
report no effects of such stressors on sucrose preference (Schmidt, Wang, & Meijer, 2011). 
Furthermore, postnatal LPS treatment has been shown to have no effect on anhedonia and 
sucrose preference in adulthood, as well as other behavioural indices of depression (Kentner, 
McLeod, Field, & Pittman, 2010; Lucchina, Carola, Pitossi, & Depino, 2010). This is 
consistent with the results from the current study, and suggests that neonatal LPS 
administration does not have long-lasting effects on anhedonia in adulthood.  
The current study revealed some evidence of sexual dimorphism in drinking 
behaviour across days, whereby males consumed more fluid than females (both water and 
sucrose solution). Results from previous research have shown that females have a heightened 
preference for, and consume greater amounts of sucrose than males (Sclafani, Hertwig, 
Vigorito, & Feigin, 1987; Curtis, Davis, Johnson, Therrien, & Contreras, 2004), although this 
finding was not replicated in the current study. Results from previous research have 
highlighted a small, but significant relationship between larger body weight and increased 
fluid consumption (Cizek & Nocenti, 1965). As all animals showed similar preference for the 
sucrose solution, the current sex difference may suggest that males consumed more fluid than 
females due larger body weight, regardless of solution preference. 
The sex differences that were observed in the various tests are consistent with results 
from previous studies. Females showed greater activity levels in the elevated plus maze and 
light dark test, while males demonstrated heightened acoustic startle response and increased 
fluid consumption. It is of interest to note that such sex differences only emerged in 
adulthood, as the results of experiment 1 (Chapter 2) did not indicate sexual dimorphism in 
any of the anxiety-related behaviours in adolescence. This suggests that sex differences may 
be dependent on developmental time period. The adolescent period commonly involves 
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heightened exploratory and risk-taking behaviour, and as such, sex differences may not 
appear until adulthood, when such behaviour is reduced.  
In summary, the present study demonstrated neonatal endotoxin exposure may not 
have long-lasting effects on voluntary and non-voluntary behavioural responses in adulthood, 
including general anxiety- and depression-related behaviour. However, early endotoxin 
exposure may have highly specific effects on certain anxiety-related behaviours assessed in 
independent ethological tests. Furthermore, acute LPS administration in adulthood does 
increase various anxiety-related behaviours. Moreover, sex differences were observed in the 
various tests of anxiety-related behaviours. The current study has important implications for 
determining adult immune outcomes for neonates exposure to bacterial infection.  
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CHAPTER 4 
General Discussion 
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4.1 General Discussion 
The present thesis examined the long-term effects of neonatal endotoxin exposure on 
various behaviours in adolescent and adult Long-Evans rats. Such studies may help to gain a 
better understanding of these effects and further identify any potential risk factors of acute 
pathogen exposure during infancy and later development, such as alterations in immune 
system functioning, anxiety and depression behaviours, and non-voluntary and voluntary 
activity.   
The dual-exposure-to-endotoxin (DEE) model of neonatal lipopolysaccharide (LPS) 
administration was utilized, which included administration of LPS on postnatal days 3 and 5, 
prior to the neonatal stress hyporesponsive period. Results of previous research have shown 
that neonatal endotoxin exposure alters various behavioural responses in adulthood following 
other adverse neonatal manipulations such as neonatal handling and maternal separation. 
However, the effects of early immune system activation during adolescence have not been 
explored in detail. The results of the first experiment suggested that early immune system 
activation resulted in increased anxiety in the elevated plus maze for both male and female 
adolescents, but had no effect on behaviours in the novel and familiar open field and light 
dark tests. Furthermore, no sex differences were observed for any of the anxiety-related 
behaviours in adolescence. 
The second experiment evaluated the effects of neonatal LPS treatment on behaviours 
in adulthood, inclusive of non-voluntary startle response and sensorimotor gating with and 
without an immune challenge in adulthood; anxiety-related behaviours following acute LPS 
administration; and taste neophobia and anhedonia independent of additional immune system 
activation. Acute LPS administration in adulthood was found to increase anxiety behaviours 
in the elevated plus maze and light-dark test, with this effect being stronger in males than 
females. Results suggested that neonatal LPS did not significantly affect adult anxiety-related 
behaviours in the elevated plus maze following adult immune system challenge. However, 
neonatal LPS resulted in reduced activity in the light chamber in adulthood related to 
neonatal saline treatment. Neonatal endotoxin treatment did not significantly affect non-
voluntary startle behaviours with or without an immune challenge in adulthood. Furthermore, 
no effect of neonatal treatment was found for taste neophobia or sucrose preference in the 
lickometer drinking test in adulthood. To better understand whether neonatal LPS 
administration has effects in a sex-specific manner, sex differences in adult behaviours were 
86 
 
investigated. Females demonstrated greater levels of activity than males in the elevated plus 
maze and light-dark test. In the startle test, male animals showed greater average startle 
responses than females, although no sex differences in prepulse inhibition were observed. 
Finally, males drank more water and sucrose solution on all test days relative to females, 
suggesting that males have a greater fluid intake regardless of solution preference.  
The varying results observed during the adolescent period are consistent with 
previous research. In a brief test of unconditioned exploration of an aversive environment 
(i.e. the elevated plus maze), neonatal LPS resulted in increased anxiety. However, in tests 
interpreting activity and locomotion as indices of anxiety, no effects were observed. The 
findings highlight the importance of using a battery of ethological tests to assess anxiety-
related behaviours. They suggest that a set of different tests may measure various aspects of 
anxiety, which may overlap with one another to produce a general index of anxiety (Ramos, 
2008). These ethological tests are all based on the natural conflict between the drive to 
explore a new environment and the tendency to avoid potentially dangerous situations. 
However, the correlation analyses between tests also indicate that the various tests may 
measure different aspects of this conflict and the resulting anxiety-related behaviour (Bourin 
& Hascoet, 2003; Walf & Frye, 2007). In adolescence, there were relatively few correlations 
between measures on the elevated plus maze and the open field and light dark tests, which 
reflect anxiety possibly unique from the confound of motor activity. In contrast, more 
correlations were found between variables in the open field (novel and familiar) and 
variables in the light-dark test, which reflect exploration and locomotor activity. This 
understanding may provide better insight into the nature and degree of overlap between tests 
and the constructs of anxiety they are measuring. 
Variable results were also observed in adulthood, as neonatal LPS did not 
significantly affect behaviours in the elevated plus maze or startle apparatus, but did result in 
specific differences in the light-dark test. Males treated neonatally with LPS travelled less in 
the light chamber than males treated with saline. This finding supports the argument that 
different tests may measure various aspects of anxiety. Furthermore, it suggests that neonatal 
LPS may have varying effects on the different constructs of anxiety at certain developmental 
stages, as anxiety-related behaviour was altered in the elevated plus maze in adolescence, but 
was altered in the light-dark test in adulthood. 
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Experiment 1 examined behaviours during the transitional developmental period of 
adolescence. No significant differences were observed between animals treated neonatally 
with LPS and those treated with saline on measures of locomotor activity in the open field 
and light-dark tests. Furthermore, no sex differences in the various behaviours were observed 
in either experiment. These findings illustrate the behavioural responses unique to the 
adolescent developmental stage, whereby all animals show less anxiety than adults, as well 
as heightened exploratory behaviour, increased risk-taking behaviour, and reduced neophagia 
(Spear, 2000; Doremus, Varlinskaya, & Spear, 2004; Stansfield & Kirstein, 2006). As such, 
the findings of the current study may represent typical adolescent behaviour across all 
animals, regardless of early immune system manipulation or sex, which is necessary for 
appropriate development and transition into adulthood (Spear, 2000; Meyza, Boguszewski, 
Niko, & Zagrodzka, 2011). Therefore, neonatal endotoxin exposure in experiment 1 did not 
result in significant changes in activity because of motivational reorganization, whereby 
adaptive behaviours associated with adolescence may have taken precedence over other 
responses such as severely enhanced anxiety.  
While the anxiety associated from the novel experiences during adolescence was 
suppressed by the increased exploratory and risk-taking behaviour common to this 
developmental period, different findings were observed in adulthood. Consistent with results 
from previous findings (e.g. Nava, et al., 1997; Lacosta et al., 1999; Nava & Carta, 2001) 
acute LPS in adulthood resulted in increased anxiety in specific behavioural measures of the 
elevated plus maze and the light-dark tests. Sickness behaviours associated with acute 
immune activation are a set of physical and behavioural symptoms to overcome the infection 
and increase survival by conserving energy and avoiding predation in a weakened state 
(Dantzer, 2001). Such a strategy is an adaptive motivational state that can be reorganized 
depending on the consequences. A fear-inducing situation may invoke escape behaviours that 
overcome sickness in order to avoid potential threat (Dantzer, 2001). Given the motivational 
state of sickness behaviour, it is possible that adult animals in experiment 2 all demonstrated 
similar anxiety-related behaviours in the elevated plus maze and light-dark tests because of 
the potentially threatening experience of a novel, anxiety-provoking environment. 
Furthermore, sex differences consistent with previous research emerged in adulthood, with 
females showing greater activity levels and less anxiety. This suggests that motivational 
reorganization can be demonstrated in a sex-specific manner. 
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Many of the results presented in this thesis revealed some inter-litter differences in 
the dependent variables. The impact of this variability is moderately reduced because of the 
within-litter nature of the experimental design, whereby each litter contained both LPS- and 
saline-treated animals, either neonatally or during adolescence. These inter-litter differences 
are likely the result of a combination of genetic, intrauterine environment and/or maternal 
behaviour influences, which have all been shown to have effects on behaviours later in life 
(e.g. Geerse, van Gurp, Wiegant, & Stam, 2006a; 2006b; Hernandez-Tristan, Leret, & 
Almeida, 2006; Liu, Diorio, Day, Francis, & Meaney, 2000).  
However, such interactions between genes and the prenatal and postnatal 
environment also influence the developmental of individual behavioural temperament 
(Trillmich & Hudson, 2011). The correlation analyses from experiment 1 highlight the 
importance of examining such individual differences and interpreting variations behaviour in 
terms of differences in animal behavioural style. Individuals adopt particular behavioural 
styles that increase the risk of survival depending on various environmental factors such as 
litter size, body mass, and maternal care, as well as potential environmental stressors (Rödel 
& Meyer, 2011). Such temperaments are often maintained throughout development and 
result in the emergence of different behavioural responses to various ethological tests 
(Groothuis & Trillmich, 2011). Results of the correlation analyses showed similar patterns of 
relationships between males and females treated neonatally with LPS or saline in the elevated 
plus maze in adolescence. However, differences between treatment were found in 
comparisons of the novel and familiar open field, associated thigmotaxis behaviours, and the 
light-dark test, with female-LPS and male-NaCl animals showing more significant 
correlations than the other treatment groups. These emphasize the importance of examining 
individual differences and highlight the effects of early environmental factors on the 
development of behavioural temperament and the resulting differences in responses to 
stressors in later life.  
The results of the correlation analysis also provide evidence for the importance of 
using multiple ethological tests when investigating behavioural responses. Very few 
significant correlations were observed between the elevated plus maze and the open field and 
light dark tests, suggesting that these may be measuring different constructs of anxiety. 
Consistent with this observation, results of previous studies have suggested that the variables 
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from the elevated plus maze and the open field do not produce a common anxiety-related 
factor in rats (Ramos, 2008).  
A more detailed analysis is required in this area to determine if behavioural 
temperaments remain stable across time. An examination of relationships between variables 
in adulthood is necessary, as well as comparisons of such correlations with those found in 
adolescence. Furthermore, future research should focus on conducting factor analysis to 
determine which tests measure similar or different constructs of anxiety and gain a better 
understand of whether these vary across developmental stage.  
These results of this thesis have potential clinical significance given that neonatal 
exposure to infection is common, particularly in the Gram negative bacterial form 
(Washburn, Medearis, & Childs, 1965). The results identify potential risk factors in infants 
exposed to early bacterial infection, including increased susceptibility to specific aspects of 
anxiety disorders at different developmental stages. Furthermore, the results also highlight 
the considerable influence of the motivation to behave in a typical adolescent manner, which 
may overcome other influences, such as immunological manipulation and heightened fear 
and anxiety. While no sex differences were observed in adolescence, sex differences were 
found in adulthood. This suggests that that sexual dimorphism may only emerge at certain 
developmental stages. The results of the current study provide an in-depth analysis of a 
developmental period that has not been explored in great detail to date, as well as resulting 
behavioural alterations in later life.   
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Appendix A:  
Significance values for EPM anxiety behaviours in adolescence: Interaction and main effects 
of Sex and Neonatal Drug Treatment 
 
 
Anxiety Behaviours 
Sex x Neonatal 
Drug 
Interaction 
Main Effect of 
Sex 
Main Effect 
of Neonatal 
Drug 
Number of entries in open arms .172  .487 .054 
Number of entries in closed arms .455  .896 .894 
Duration of time in closed arms .386  .196 .443 
Percent time in open arms .242  .527 .017 * 
Number of head stretch attends .811  .665 .189 
Duration of head stretch attends  .711  .300 .247 
Number of body stretch attends .434  .557 .949 
Duration of body stretch attends  .768  .062 .941 
Head dips .212  .098 .759 
Number of closed arm re-entries .123  .959 .816 
 
Note. Significance is set at α = .05 and * indicates significance.  
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Appendix B: 
Significance values for locomotor activity: Interaction and main effects of Sex and Neonatal 
Drug Treatment, main effects of time and day 
 
 
 
Locomotor Activity 
Sex x Neonatal 
Drug 
Interaction 
Main Effect 
of Sex 
Main Effect 
of Neonatal 
Drug 
Main 
Effect 
of Time 
Main 
Effect of 
Day 
 Day 
39 
Day 
40 
Day 
39 
Day 
40 
Day 
39 
Day 
40 
  
Total Distance (cm) .744 .951 .981 .981 .919 .986 .001* .001* 
Movement Time (s) .698 .904 .879 .982 .647 .702 .001* .001* 
Horizontal Movements .701 .949 .255 .389 .563 .269 .001* .001* 
Vertical Movements .588 .991 .961 .679 .886 .794 .001* .001* 
 
Note. Significance is set at α = .05 and * indicates significance.  
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Appendix C: 
Significance values for thigmotaxis: Interaction and main effects of Sex and Neonatal Drug 
Treatment 
 
 
 
 
Thigmotaxis behaviours 
Sex x 
Neonatal 
Drug 
Interaction 
 
 
Main Effect 
of Sex 
 
 
Main Effect of 
Neonatal Drug 
 Day 
39 
Day 
40 
Day 
39 
Day 
40 
Day 
39 
Day 
40 
Total Duration in Periphery (s) .648 .551 .120 .705 .906 .861 
Total Duration in Center (s) .648 .551 .120 .705 .906 .861 
Total Vertical Time in Periphery (s) .735 .763 .268 .631 .355 .904 
Total Vertical Time in Center (s) .720 .980 .148 .611 .527 .838 
Total Number of Entries in Periphery .392 .778 .857 .818 .747 .444 
Total Number of Entries in Center .393 . 780 .869 .815 .744 .445 
 
Note. Significance is set at α = .05 and * indicates significance.  
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Appendix D: 
Significance values for light-dark activity measures in adolescence: Interaction and main 
effects of Sex and Neonatal Drug Treatment 
 
 Light Dark 
 
Activity Measures 
Sex x 
Drug 
Main 
Effect 
of Sex 
Main 
Effect of 
Drug 
Sex x 
Drug  
Main 
Effect 
of Sex 
Main 
Effect of 
Drug 
Number of entries  .847 .714 .949 .400 .496 .303 
Duration of time in 
chamber (s) 
.855 .492 .458 .892 .467 .368 
Total distance in 
chamber (cm/min) 
.178 .952 .808 .899 .064 .335 
Vertical movements 
in chamber (cm/min) 
.744 .886 .662 .019* .399 .361 
Duration of vertical 
movements in 
chamber (cm/min) 
.644 .828 .158 .746 .419 .695 
 
Note. Significance is set at α = .05 and * indicates significance.  
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Appendix E: 
Significance values for EPM anxiety behaviours in adulthood: Interaction and main effects of 
Sex and Neonatal Drug Treatment 
 
 
Anxiety Behaviours 
Sex x Neonatal 
Drug 
Interaction 
Main Effect of 
Sex 
Main Effect 
of Neonatal 
Drug 
Number of entries in open arms .782 .024* .850 
Number of entries in closed arms .918  .187 .710 
Amount of time spent in closed arms .793  .987 .889 
Percent time in open arms .875  .005* .470 
Number of head stretch attends .434  .513 .675 
Duration of head stretch attends  .483  .549 .961 
Number of body stretch attends .803  .134 .576 
Duration of body stretch attends  .675  .817 .961 
Head dips .434  .538 .989 
Double backs .296  .205 .286 
 
Note. Significance is set at α = .05 and * indicates significance.  
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Appendix F: 
Significance values for light-dark activity measures in adulthood: Interaction and main 
effects of Sex and Neonatal Drug Treatment 
 
 Light Dark 
 
Activity Measures 
Sex x 
Drug 
Main 
Effect 
of Sex 
Main 
Effect of 
Drug 
Sex x 
Drug  
Main 
Effect 
of Sex 
Main 
Effect of 
Drug 
Number of entries  .280 .870 .531 .678 .106 .072 
Duration of time in 
chamber (s) 
.590 .451 .123 .582 .459 .129 
Total distance in 
chamber (cm/min) 
.042* .269 .492 .930 .419 .162 
Vertical movements 
in chamber (cm/min) 
.102 .618 .602 .781 .573 .199 
Duration of vertical 
movements in 
chamber (cm/min) 
.455 .629 .152 .683 .314 .068 
 
Note. Significance is set at α = .05 and * indicates significance. 
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Appendix G: 
Significance values for average startle response and percent PPI in adulthood: Interaction and 
main effects of Sex and Neonatal Drug Treatment 
 
 Day 70 Day 72 
 
Activity Measures 
Sex x 
Drug 
Main 
Effect of 
Sex 
Main 
Effect of 
Drug 
Sex x 
Drug  
Main 
Effect 
of Sex 
Main 
Effect of 
Drug 
Average startle  .278 .002* .341 .349 .001* .248 
Percent PPI – ISI of 60 ms .975 .445 .682 .297 .935 .311 
Percent PPI – ISI of 100 ms .978 .377 .941 .329 .227 .181 
 
Note. Significance is set at α = .05 and * indicates significance. 
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Appendix H: 
Significance values for novel sucrose drinking behaviours in adulthood: Interaction and main 
effects of Sex and Neonatal Drug Treatment 
 
Drinking Behaviours Sex x Neonatal 
Drug 
Interaction 
Main Effect of 
Sex 
Main Effect 
of Neonatal 
Drug 
Volume intake .438 .338 .640 
Number of Licks .830 .114 .905 
Size of Bursts .985 .709 .551 
Number of Bursts .716 .483 .416 
Size of Clusters .928 .755 .803 
Number of Clusters .589 .663 .519 
 
Note. Significance is set at α = .05 and * indicates significance 
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Appendix I: 
Significance values for familiar sucrose drinking behaviours across days (baseline, sucrose 
day 1 and sucrose day 2) in adulthood: Interaction and main effects of Sex and Neonatal 
Drug Treatment 
 
Drinking Behaviours Sex x Neonatal 
Drug 
Interaction 
Main Effect of 
Sex 
Main Effect 
of Neonatal 
Drug 
Volume intake .185 .001* .041* 
Number of Licks .777 .761 .095 
Size of Bursts .339 .253 .911 
Number of Bursts .803 .592 .493 
Size of Clusters .368 .825 .980 
Number of Clusters .253 .537 .498 
 
Note. Significance is set at α = .05 and * indicates significance
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1 1 .548* .067 -.734** -.604** .961** .878** -.180 -.405 .643** .329 -.194 -.217 -.399 -.265 .549* .649** .521* .193
1 1 .674 ** .248 -.760** -.735** .935 ** .924 ** -.292 -.210 -.023 .582 ** -.094 .312 -.305 -.134 .603 ** .248 .467 * .121
1 1 -.707** .179 .367 -.071 .360 .146 .479* .199 .489* -.015 .250 -.240 .737** .345 .513* .066
1 1 -.532* -.302 .613 ** .160 .188 .221 -.098 .038 -.138 .406 -.223 .045 .823 ** .540 * .431 .307
1 1 -.609** -.624** .066 .094 -.814** -.395 -.090 .038 .229 .084 -.717** -.375 -.608** -.262
1 1 -.804** -.730** .270 .136 -.356 -.357 .300 -.405 .367 -.107 -.702** -.456* -.855** -.328
1 1 -.252 -.049 .435 .357 -.063 .156 -.263 .107 .616** .481* .762** .064
1 1 -.257 -.232 .069 .591 ** .076 .238 -.241 -.202 .522 * .188 .512 * .132
1 1 -.165 -.331 .317 .286 .679** .206 .241 -.267 .064 -.245
1 1 -.327 -.265 .072 .379 .032 .149 .045 .332 -.135 .208
1 1 .101 -.130 -.184 -.265 .475* .113 .482* .160
1 1 .060 .161 -.292 .019 -.016 .123 .185 -.054
1 1 .674** .678** .454* .065 .352 .307
1 1 .676 ** .592 ** -.300 .578 ** -.361 .388
1 1 .154 -.014 .103 .207
1 1 -.380 .356 -.224 .204
1 1 .887
** .699**
1 1 .685 ** .854 **
1 1
1 1
F G H I JA B C D E
J Duration of body stretch attends
G Number of head stretch attends
H Duration of head stretch attends
I Number of body stretch attends
D Percent time in open arms
E Number of closed arm re-entries
F Number of head dips
A Number of open arm entries
B Number of closed arm entries
C Duration in closed arms
 Appendix J: Correlation table within elevated plus maze variables in adolescence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Significance is set at α = .05; *p <.05, **p <.001 
Left – females; Right – males; Bolded – neonatal LPS treatment; Unbolded – neonatal NaCl
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1 1 .920** .941** .979** .990** .830** .884** .805** .655**
1 1 .959 ** .922 ** .983 ** .970 ** .897 ** .890 ** .813 ** .883 **
1 1 .948** .956** .783** .820** .896** .726**
1 1 .958 ** .965 ** .879 ** .882 ** .855 ** .913 **
1 1 .833** .877** .821** .631**
1 1 .924 ** .904 ** .776 ** .870 **
1 1 .694** .683**
1 1 .701 ** .793 **
1 1
1 1
D Vertical movements in 
novel open field
E Vertical time in novel open field 
A Total distance in novel 
open field 
B Horizontal movements 
in novel open field
C Movement time  in novel 
open field
DCBA E
1 1 .961** .900** .983** .959** .909** .754** .687** .689**
1 1 .946** .891** .986** .973** .866** .836** .862** .700**
1 1 .958** .942** .883** .705** .753** .736**
1 1 .956** .901** .832** .798** .881** .846**
1 1 .889** .762** .686** .619**
1 1 .892** .846** .843** .702**
1 1 .609** .664**
1 1 .654** .554**
1 1
1 1
Vertical time in familiar 
open field
A
B
C
D
E
Total distance in familiar 
open field
Horizontal movements 
in familiar open field
Movement time in 
familiar open field
Vertical movements in 
familiar open field
A B C D E
Appendix K1: Correlation table within novel open field variables in adolescence 
 
 
 
 
 
 
Appendix K2: Correlation table within familiar open field variables in adolescence 
 
 
 
 
 
 
 
 
Note. Significance is set at α = .05; *p <.05, **p <.001 
Left – females; Right – males; Bolded – neonatal LPS treatment; Unbolded – neonatal NaCl   
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1 1 .303 .401 .202 .479*
1 1 .506 * .199 .618 ** .310
1 1 .877** .724**
1 1 .892 ** .731 **
1 1
1 1
C
Number of entries into center 
area in novel open field
B C
A
Duration in periphery in 
novel open field
B
Vertical time in periphery in 
novel open field
A
1 1 .508* .511* .331 .523*
1 1 .348 .595 ** .369 .586 **
1 1 .820** .697**
1 1 .917 ** .712 **
1 1
1 1C
Number of entries into center 
area in familiar open field
A
Duration in periphery in 
familiar open field
B
Vertical time in periphery in 
familiar open field
A B C
Appendix L1: Correlation table within novel thigmotaxis variables in adolescence 
 
 
 
 
 
 
 
 
 
Appendix L2: Correlation table within familiar thigmotaxis variables in adolescence 
 
 
 
 
 
 
 
 
Note. Significance is set at α =.05; *p <.05, **p <.001 
Left – females; Right – males; Bolded – neonatal LPS treatment; Unbolded – neonatal NaCl  
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1 1 .173 -.130 -.345 .206 -.094 .172 .253 .268 .445* .323 -.140 .152 .174 .026 .030 -.082 .097 .053
1 1 .173 .349 .351 -.401 -.450* -.384 -.370 -.121 .706 ** .627 ** -.173 -.349 .343 .042 .131 .113 .154 .186
1 1 -.820** -.831** -.795** -.775** -.536* -.596** .852** .718** -.996** -.997** .967** .760** .374 .853** .173 .700**
1 1 -.337 -.743** -.431 -.821** -.515* -.620** .493 * .689 ** -1.000** -1.000** .816 ** .663 ** .527 * .319 .118 -.041
1 1 .592** .692** .162 .501* -.734** -.489* .815** .827** -.698** -.488* -.377 -.700** -.286 -.552**
1 1 -.551* .517 * -.469* .332 .217 -.420 .337 .743 ** -.015 -.219 .035 -.107 .201 .014
1 1 .711** .837** -.699** -.586** .791** .791** -.760** -.628** -.240 -.643** -.131 -.504*
1 1 .952 ** .657 ** -.599** -.674** .431 .821 ** -.505* -.540* -.366 -.178 -.318 .101
1 1 -.426 -.445* .546* .616** -.550* -.494* -.081 -.431* .077 -.204
1 1 -.600** -.546* .515 * .620 ** -.564** -.326 -.435 -.067 -.338 .434 *
1 1 -.834** -.711** .830** .485* .097 .514* .012 .484*
1 1 -.493* -.689** .571 ** .401 .305 .218 .333 -.072
1 1 -.962** -.771** -.367 -.852** -.166 -.692**
1 1 -.816** -.663** -.527* -.319 -.118 .041
1 1 .339 .876** .127 .740**
1 1 .748 ** .755 ** .437 .409
1 1 .922** .822**
1 1 .732 ** .709 **
1 1
1 1J
Duration of 
vertical 
movements in 
dark chamber
G Duration in 
dark chamber
H
Total distance 
in dark 
chamber
I
Vertical 
movements in 
dark chamber
D
Vertical 
movements in 
light chamber
E
Duration of 
vertical 
movements in 
light chamber
F
Number of 
entires into 
dark chamber
A
Number of 
entries into 
light chamber
B Duration in 
light chamber
C
Total distance 
in light 
chamber
DCBA JIHGFE
Appendix M: Correlation table within light-dark test variables in adolescence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Significance is set at α =.05; *p <.05, **p <.001 
Left – females; Right – males; Bolded – neonatal LPS treatment; Unbolded – neonatal NaCl
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